School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Jonathan Glass MD

  • Department of Neurology
    Professor
  • (404) 727-3507
  • jglas03@emory.edu
  • Emory ALS Center
Head shot of Jonathan Glass

Academic Appointment

  • Professor, Neurology, Emory University
  • Professor, Pathology, Emory University

Education

Degrees

  • MD from University of Vermont
  • Student Fellowship - Department of Neurology from University of Vermont
  • BA from Middlebury College

Research

Focus

  • Mechanisms of axonal degeneration in models of peripheral neuropathy Experimental therapies in peripheral neuropathy Mechanisms and models in motor neuron diseases/ALS Therapeutic interventions for ALS

Publications

  • Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral Sclerosis.
    Muscle Nerve Volume: 71 Page(s): 1006 - 1015
    06/01/2025 Authors: Lovett A; Chary S; Babu S; Bruneteau G; Glass JD; Karlsborg M; Ladha S; Mayl K; McDermott C; Bucelli RC
  • Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosis.
    Mol Neurodegener Volume: 20 Page(s): 58
    05/15/2025 Authors: Trautwig AN; Fox EJ; Dammer EB; Shantaraman A; Ping L; Duong DM; Watson CM; Wu F; Asress S; Guo Q
  • Risk prediction for ALS using semi-competing risk models with applications to the ALS Natural History Consortium dataset.
    Amyotroph Lateral Scler Frontotemporal Degener Page(s): 1 - 8
    05/14/2025 Authors: Arguedas A; Schneck D; Cui E; Xenopoulos-Oddsson A; Arcila-Londono X; Lunetta C; Wymer J; Olney N; Gwathmey K; Ajroud-Driss S
  • Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencing.
    Nat Commun Volume: 16 Page(s): 3914
    04/25/2025 Authors: Pottier C; Kkali F; Baker M; Batzler A; Jenkins GD; van Blitterswijk M; Vicente CT; De Coster W; Wynants S; Van de Walle P
  • Time-to-event prediction in ALS using a landmark modeling approach, using the ALS Natural History Consortium dataset.
    Amyotroph Lateral Scler Frontotemporal Degener Page(s): 1 - 9
    04/02/2025 Authors: Schneck D; Arguedas A; Xenopoulos-Oddsson A; Arcila-Londono X; Lunetta C; Wymer J; Olney N; Gwathmey K; Ajroud-Driss S; Hayat G
  • Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.
    JAMA Neurol Volume: 82 Page(s): 333 - 343
    04/01/2025 Authors: Writing Committee for the HEALEY ALS Platform Trial; Andrews J; Paganoni S; Macklin EA; Chibnik LB; Quintana M; Saville BR; Detry MA; Vestrucci M; Marion J
  • ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression.
    Ann Clin Transl Neurol Volume: 12 Page(s): 714 - 723
    04/01/2025 Authors: Thomas EV; Han C; Kim WJ; Asress S; Li Y; Taylor JA; Gearing M; Fournier CN; McEachin ZT; Seyfried NT
  • ALS Motor Observational Telemedicine Objective Rasch-Built Assessment: A Quantitative Scale for the Era of Teleneurology.
    Neurol Clin Pract Volume: 15 Page(s): e200432
    04/01/2025 Authors: Fournier CN; Levine M; Simmons K; Garca-Santibez RC; Rowland A; Quinn CC; Ho DT; Bedlack RS; Glass JD
  • ALSUntangled #78: Zinc.
    Amyotroph Lateral Scler Frontotemporal Degener Page(s): 1 - 5
    03/14/2025 Authors: Helmold B; Nathaniel G; Barkhaus P; Bertorini T; Bromberg M; Brown A; Carter GT; Chang V; Crayle J; Denson K
  • pTDP-43 levels correlate with cell type-specific molecular alterations in the prefrontal cortex of C9orf72 ALS/FTD patients.
    Proc Natl Acad Sci U S A Volume: 122 Page(s): e2419818122
    03/04/2025 Authors: Wang H-LV; Xiang J-F; Yuan C; Veire AM; Gendron TF; Murray ME; Tansey MG; Hu J; Gearing M; Glass JD
  • CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
    JAMA Volume: 333 Page(s): 1138 - 1149
    02/17/2025 Authors: Writing Committee for the HEALEY ALS Platform Trial; Berry JD; Maragakis NJ; Macklin EA; Chibnik LB; Quintana M; Saville BR; Detry MA; Vestrucci M; Marion J
  • Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implications.
    J Neurol Neurosurg Psychiatry
    02/13/2025 Authors: Iacoangeli A; Dilliott AA; Al Khleifat A; Andersen PM; Baak NA; Cooper-Knock J; Corcia P; Couratier P; deCarvalho M; Drory VE
  • Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
    JAMA Netw Open Volume: 8 Page(s): e2459058
    02/03/2025 Authors: Paganoni S; Fournier CN; Macklin EA; Chibnik LB; Quintana M; Saville BR; Detry MA; Vestrucci M; Marion J; McGlothlin A
  • ALSUntangled #76: Wahls protocol.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 26 Page(s): 181 - 185
    02/01/2025 Authors: Li X; Wicks P; Brown A; Shivaprasad A; Greene M; Crayle J; Barnes B; Jhooty S; Ratner D; Olby N
  • Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data.
    Cell Genom Volume: 4 Page(s): 100679
    11/13/2024 Authors: Saez-Atienzar S; Souza CDS; Chia R; Beal SN; Lorenzini I; Huang R; Levy J; Burciu C; Ding J; Gibbs JR
  • Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study.
    Lancet Neurol Volume: 23 Page(s): 901 - 912
    09/01/2024 Authors: van den Berg LH; Rothstein JD; Shaw PJ; Babu S; Benatar M; Bucelli RC; Genge A; Glass JD; Hardiman O; Libri V
  • Author Correction: The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration.
    Nat Commun Volume: 15 Page(s): 5560
    07/02/2024 Authors: Opie-Martin S; Iacoangeli A; Topp SD; Abel O; Mayl K; Mehta PR; Shatunov A; Fogh I; Bowles H; Limbachiya N
  • pTDP-43 levels correlate with cell type specific molecular alterations in the prefrontal cortex of C9orf72 ALS/FTD patients.
    bioRxiv
    06/13/2024 Authors: Wang H-LV; Xiang J-F; Yuan C; Veire AM; Gendron TF; Murray ME; Tansey MG; Hu J; Gearing M; Glass JD
  • Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls.
    Nat Commun Volume: 15 Page(s): 3606
    05/02/2024 Authors: Tsitkov S; Valentine K; Kozareva V; Donde A; Frank A; Lei S; Answer ALS Consortium; E Van Eyk J; Finkbeiner S; Rothstein JD
  • ALSUntangled #73: Lion's Mane.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 25 Page(s): 420 - 423
    05/01/2024 Authors: Muhanna M; Lund I; Bromberg M; Wicks P; Benatar M; Barnes B; Pierce K; Ratner D; Brown A; Bertorini T
  • The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 25 Page(s): 382 - 387
    05/01/2024 Authors: Genge A; Cedarbaum JM; Shefner J; Chio A; Al-Chalabi A; Van Damme P; McDermott C; Glass J; Berry J; van Eijk RPA
  • Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD.
    Sci Transl Med Volume: 16 Page(s): eadg7162
    02/14/2024 Authors: Seddighi S; Qi YA; Brown A-L; Wilkins OG; Bereda C; Belair C; Zhang Y-J; Prudencio M; Keuss MJ; Khandeshi A
  • Cryptic exon inclusion is a molecular signature ofLATE-NCin aging brains.
    Acta Neuropathol Volume: 147 Page(s): 29
    02/03/2024 Authors: Chung M; Carter EK; Veire AM; Dammer EB; Chang J; Duong DM; Raj N; Bassell GJ; Glass JD; Gendron TF
  • The importance of understanding minimal important difference for ALSFRS-R: A reply to 'Do we really need to calculate a minimal important difference for ALSFRS-R?' https://doi.org/10.1080/21678421.2023.2248199.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 25 Page(s): 216 - 217
    02/01/2024 Authors: Fournier CN; Glass JD
  • Toward a generalizable machine learning workflow for neurodegenerativedisease staging with focus on neurofibrillary tangles.
    Acta Neuropathol Commun Volume: 11 Page(s): 202
    12/18/2023 Authors: Vizcarra JC; Pearce TM; Dugger BN; Keiser MJ; Gearing M; Crary JF; Kiely EJ; Morris M; White B; Glass JD
  • Genetic variability in sporadic amyotrophic lateral sclerosis.
    Brain Volume: 146 Page(s): 3760 - 3769
    09/01/2023 Authors: Van Daele SH; Moisse M; van Vugt JJFA; Zwamborn RAJ; van der Spek R; van Rheenen W; Van Eijk K; Kenna K; Corcia P; Vourc'h P
  • Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis.
    Ann Neurol Volume: 94 Page(s): 547 - 560
    09/01/2023 Authors: Quintana M; Saville BR; Vestrucci M; Detry MA; Chibnik L; Shefner J; Berry JD; Chase M; Andrews J; Sherman AV
  • ALSUntangled #67: rituximab.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 24 Page(s): 544 - 547
    08/01/2023 Authors: Li X; Armon C; Barkhaus P; Barnes B; Benatar M; Bertorini T; Bromberg M; Carter GT; Crayle J; Cudkowicz M
  • Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial.
    Cell Rep Med Volume: 4 Page(s): 101025
    05/16/2023 Authors: Ranjan T; Sengupta S; Glantz MJ; Green RM; Yu A; Aregawi D; Chaudhary R; Chen R; Zuccarello M; Lu-Emerson C
  • Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-R.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 24 Page(s): 311 - 316
    05/01/2023 Authors: Fournier CN; James V; Glass JD
  • Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD.
    bioRxiv
    01/23/2023 Authors: Seddighi S; Qi YA; Brown A-L; Wilkins OG; Bereda C; Belair C; Zhang Y; Prudencio M; Keuss MJ; Khandeshi A
  • Large-scale analyses of CAV1 and CAV2 suggest their expression is higher in post-mortem ALS brain tissue and affects survival.
    Front Cell Neurosci Volume: 17 Page(s): 1112405
    01/01/2023 Authors: Adey BN; Cooper-Knock J; Al Khleifat A; Fogh I; van Damme P; Corcia P; Couratier P; Hardiman O; McLaughlin R; Gotkine M
  • Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A Review.
    JAMA Neurol Volume: 79 Page(s): 1312 - 1318
    12/01/2022 Authors: Shefner JM; Bedlack R; Andrews JA; Berry JD; Bowser R; Brown R; Glass JD; Maragakis NJ; Miller TM; Rothstein JD
  • The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration.
    Nat Commun Volume: 13 Page(s): 6901
    11/12/2022 Authors: Opie-Martin S; Iacoangeli A; Topp SD; Abel O; Mayl K; Mehta PR; Shatunov A; Fogh I; Bowles H; Limbachiya N
  • Interrogating the Metabolomic Profile of Amyotrophic Lateral Sclerosis in the Post-Mortem Human Brain by Infrared Matrix-Assisted Laser Desorption Electrospray Ionization (IR-MALDESI) Mass Spectrometry Imaging (MSI).
    Metabolites Volume: 12
    11/10/2022 Authors: Sohn AL; Ping L; Glass JD; Seyfried NT; Hector EC; Muddiman DC
  • ALSUntangled #64: butyrates.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 23 Page(s): 638 - 643
    11/01/2022 Authors: Sun Y; Bedlack R; Armon C; Beauchamp M; Bertorini T; Bowser R; Bromberg M; Caress J; Carter G; Crayle J
  • Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy.
    Mov Disord Volume: 37 Page(s): 2110 - 2121
    10/01/2022 Authors: Hopfner F; Tietz AK; Ruf VC; Ross OA; Koga S; Dickson D; Aguzzi A; Attems J; Beach T; Beller A
  • Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
    N Engl J Med Volume: 387 Page(s): 1099 - 1110
    09/22/2022 Authors: Miller TM; Cudkowicz ME; Genge A; Shaw PJ; Sobue G; Bucelli RC; Chi A; Van Damme P; Ludolph AC; Glass JD
  • Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data.
    Nat Comput Sci Volume: 2 Page(s): 605 - 616
    09/01/2022 Authors: Ramamoorthy D; Severson K; Ghosh S; Sachs K; Answer ALS; Glass JD; Fournier CN; Pooled Resource Open-Access ALS Clinical Trials Consortium; ALS/MND Natural History Consortium; Herrington TM
  • ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
    Brain Volume: 145 Page(s): 2671 - 2676
    08/27/2022 Authors: Glass JD; Dewan R; Ding J; Gibbs JR; Dalgard C; Keagle PJ; Shankaracharya; Garca-Redondo A; Traynor BJ; Chia R
  • ALS-linked KIF5A Exon27 mutant causes neuronal toxicity through gain-of-function.
    EMBO Rep Volume: 23 Page(s): e54234
    08/03/2022 Authors: Pant DC; Parameswaran J; Rao L; Loss I; Chilukuri G; Parlato R; Shi L; Glass JD; Bassell GJ; Koch P
  • Efficacy and Safety of Apatinib for Radiation-induced Brain Injury Among Patients With Head and Neck Cancer: An Open-Label, Single-Arm, Phase 2 Study.
    Int J Radiat Oncol Biol Phys Volume: 113 Page(s): 796 - 804
    07/15/2022 Authors: He L; Pi Y; Li Y; Wu Y; Jiang J; Rong X; Cai J; Yue Z; Cheng J; Li H
  • Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis.
    Neuron Volume: 110 Page(s): 992 - 1008.e11
    03/16/2022 Authors: Zhang S; Cooper-Knock J; Weimer AK; Shi M; Moll T; Marshall JNG; Harvey C; Nezhad HG; Franklin J; Souza CDS
  • Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
    Nat Genet Volume: 54 Page(s): 361
    03/01/2022 Authors: van Rheenen W; van der Spek RAA; Bakker MK; van Vugt JJFA; Hop PJ; Zwamborn RAJ; de Klein N; Westra H-J; Bakker OB; Deelen P
  • Erratum to Letters to the Editor regarding: The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy. J Neuropathol Exp Neurol 2021;80(3):210-9.
    J Neuropathol Exp Neurol Volume: 81 Page(s): 249
    02/24/2022 Authors: Glass JD; Hammers JL; Omalu BL; Bieniek KF; Crary JF; Dickson DW; Stein TD; Mez J; Alosco ME; McKee AC
  • Unintended Consequences of Approving Unproven Treatments-Hope, Hype, or Harm?
    JAMA Neurol Volume: 79 Page(s): 117 - 118
    02/01/2022 Authors: Glass JD; Fournier CN
  • Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development.
    Ann Neurol Volume: 91 Page(s): 165 - 175
    02/01/2022 Authors: Paganoni S; Berry JD; Quintana M; Macklin E; Saville BR; Detry MA; Chase M; Sherman AV; Yu H; Drake K
  • Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines.
    Nat Neurosci Volume: 25 Page(s): 226 - 237
    02/01/2022 Authors: Baxi EG; Thompson T; Li J; Kaye JA; Lim RG; Wu J; Ramamoorthy D; Lima L; Vaibhav V; Matlock A
  • Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 23 Page(s): 91 - 99
    02/01/2022 Authors: Hertzberg VS; Singh H; Fournier CN; Moustafa A; Polak M; Kuelbs CA; Torralba MG; Tansey MG; Nelson KE; Glass JD
  • Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis.
    NPJ Genom Med Volume: 7 Page(s): 8
    01/28/2022 Authors: Al Khleifat A; Iacoangeli A; van Vugt JJFA; Bowles H; Moisse M; Zwamborn RAJ; van der Spek RAA; Shatunov A; Cooper-Knock J; Topp S
  • A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS.
    Ann Clin Transl Neurol Volume: 9 Page(s): 50 - 66
    01/01/2022 Authors: Katz JS; Rothstein JD; Cudkowicz ME; Genge A; Oskarsson B; Hains AB; Chen C; Galanter J; Burgess BL; Cho W
  • Genome-wide association study and functional validation implicates JADE1 in tauopathy.
    Acta Neuropathol Volume: 143 Page(s): 33 - 53
    01/01/2022 Authors: Farrell K; Kim S; Han N; Iida MA; Gonzalez EM; Otero-Garcia M; Walker JM; Richardson TE; Renton AE; Andrews SJ
  • Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence data.
    Front Cell Neurosci Volume: 16 Page(s): 1050596
    01/01/2022 Authors: Al Khleifat A; Iacoangeli A; Jones AR; van Vugt JJFA; Moisse M; Shatunov A; Zwamborn RAJ; van der Spek RAA; Cooper-Knock J; Topp S
  • Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
    Nat Genet Volume: 53 Page(s): 1636 - 1648
    12/01/2021 Authors: van Rheenen W; van der Spek RAA; Bakker MK; van Vugt JJFA; Hop PJ; Zwamborn RAJ; de Klein N; Westra H-J; Bakker OB; Deelen P
  • Re: The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy. J Neuropathol Exp Neurol 2021;80(3):210-9.
    J Neuropathol Exp Neurol Volume: 80 Page(s): 1007 - 1008
    10/26/2021 Authors: Glass JD
  • Amyotrophic Lateral Sclerosis Genetic Access Program: Paving the Way for Genetic Characterization of ALS in the Clinic.
    Neurol Genet Volume: 7 Page(s): e615
    10/01/2021 Authors: Roggenbuck J; Rich KA; Vicini L; Palettas M; Schroeder J; Zaleski C; Lincoln T; Drury L; Glass JD
  • Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis.
    JAMA Neurol Volume: 78 Page(s): 1236 - 1248
    10/01/2021 Authors: Johnson JO; Chia R; Miller DE; Li R; Kumaran R; Abramzon Y; Alahmady N; Renton AE; Topp SD; Gibbs JR
  • IN VIVO BIOLOGIC ACTIVITY OF INDUCED HYBRID T-REG/TH2 RAPA-501 CELLS FOR ALS THERAPY: CORRECTION OF T-SCM:T-EM IMBALANCE, NORMALIZATION OF IL-6 SECRETION, AND REDUCTION IN SERUM NF-L LEVELS
    Volume: 23 Page(s): S102 - S102
    05/01/2021 Authors: Felizardo T; Lum LG; Ashmaig M; Limas SM; Zhu N; Bushera H; Glass D; Berry J; Korngold R; Donato M
  • INDUCED HYBRID T-REG/TH2 RAPA-501 CELLS FOR THERAPY OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
    Volume: 23 Page(s): S101 - S102
    05/01/2021 Authors: Felizardo T; Berry J; Limas SM; Zhu N; Bushera H; Glass D; Munshi P; Rowley S; Korngold R; Donato M
  • Looking backward to move forward: a meta-analysis of stem cell therapy in amyotrophic lateral sclerosis.
    NPJ Regen Med Volume: 6 Page(s): 20
    04/01/2021 Authors: Morata-Tarifa C; Azkona G; Glass J; Mazzini L; Sanchez-Pernaute R
  • The Effect of SMN Gene Dosage on ALS Risk and Disease Severity.
    Ann Neurol Volume: 89 Page(s): 686 - 697
    04/01/2021 Authors: Moisse M; Zwamborn RAJ; van Vugt J; van der Spek R; van Rheenen W; Kenna B; Van Eijk K; Kenna K; Corcia P; Couratier P
  • Comparison of Phenotypic Characteristics and Prognosis Between Black and White Patients in a Tertiary ALS Clinic.
    Neurology Volume: 96 Page(s): e840 - e844
    02/09/2021 Authors: Brand D; Polak M; Glass JD; Fournier CN
  • Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
    Neuron Volume: 109 Page(s): 448 - 460.e4
    02/03/2021 Authors: Dewan R; Chia R; Ding J; Hickman RA; Stein TD; Abramzon Y; Ahmed S; Sabir MS; Portley MK; Tucci A
  • Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy.
    J Neuropathol Exp Neurol Volume: 80 Page(s): 102 - 111
    01/20/2021 Authors: Walker JM; Richardson TE; Farrell K; Iida MA; Foong C; Shang P; Attems J; Ayalon G; Beach TG; Bigio EH
  • Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemic.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 22 Page(s): 22 - 32
    01/01/2021 Authors: Beaulieu D; Berry JD; Paganoni S; Glass JD; Fournier C; Cuerdo J; Schactman M; Ennist DL
  • Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis.
    Muscle Nerve Volume: 63 Page(s): 31 - 39
    01/01/2021 Authors: Paganoni S; Hendrix S; Dickson SP; Knowlton N; Macklin EA; Berry JD; Elliott MA; Maiser S; Karam C; Caress JB
  • Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene.
    Cell Rep Volume: 33 Page(s): 108456
    12/01/2020 Authors: Cooper-Knock J; Zhang S; Kenna KP; Moll T; Franklin JP; Allen S; Nezhad HG; Iacoangeli A; Yacovzada NY; Eitan C
  • Stathmin-2: adding another piece to the puzzle of TDP-43 proteinopathies and neurodegeneration.
    J Clin Invest Volume: 130 Page(s): 5677 - 5680
    11/02/2020 Authors: Glass JD
  • Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease.
    Sci Adv Volume: 6
    10/01/2020 Authors: Higginbotham L; Ping L; Dammer EB; Duong DM; Zhou M; Gearing M; Hurst C; Glass JD; Factor SA; Johnson ECB
  • A nomogram to predict symptomatic epilepsy in patients with radiation-induced brain necrosis.
    Neurology Volume: 95 Page(s): e1392 - e1403
    09/08/2020 Authors: Huang X; Zhang X; Wang X; Rong X; Li Y; Li H; Jiang J; Cai J; Zhuo X; Pi Y
  • Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.
    N Engl J Med Volume: 383 Page(s): 919 - 930
    09/03/2020 Authors: Paganoni S; Macklin EA; Hendrix S; Berry JD; Elliott MA; Maiser S; Karam C; Caress JB; Owegi MA; Quick A
  • Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunities.
    Muscle Nerve Volume: 62 Page(s): 182 - 186
    08/01/2020 Authors: Andrews JA; Berry JD; Baloh RH; Carberry N; Cudkowicz ME; Dedi B; Glass J; Maragakis NJ; Miller TM; Paganoni S
  • Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36.
    Neuron Volume: 107 Page(s): 292 - 305.e6
    07/22/2020 Authors: McEachin ZT; Gendron TF; Raj N; Garca-Murias M; Banerjee A; Purcell RH; Ward PJ; Todd TW; Merritt-Garza ME; Jansen-West K
  • Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
    N Engl J Med Volume: 383 Page(s): 109 - 119
    07/09/2020 Authors: Miller T; Cudkowicz M; Shaw PJ; Andersen PM; Atassi N; Bucelli RC; Genge A; Glass J; Ladha S; Ludolph AL
  • Tau deposition in the spinal cord is not specific for CTE-ALS.
    Neurology Volume: 95 Page(s): 37 - 39
    07/07/2020 Authors: Fournier CN; Gearing M; Glass JD
  • Longitudinal biomarkers in amyotrophic lateral sclerosis.
    Ann Clin Transl Neurol Volume: 7 Page(s): 1103 - 1116
    07/01/2020 Authors: Huang F; Zhu Y; Hsiao-Nakamoto J; Tang X; Dugas JC; Moscovitch-Lopatin M; Glass JD; Brown RH; Ladha SS; Lacomis D
  • Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma.
    J Neurooncol Volume: 147 Page(s): 653 - 661
    05/01/2020 Authors: Song A; Bar-Ad V; Martinez N; Glass J; Andrews DW; Judy K; Evans JJ; Farrell CJ; Werner-Wasik M; Chervoneva I
  • Validation of machine learning models to detect amyloid pathologies across institutions.
    Acta Neuropathol Commun Volume: 8 Page(s): 59
    04/28/2020 Authors: Vizcarra JC; Gearing M; Keiser MJ; Glass JD; Dugger BN; Gutman DA
  • The Rasch-Built Overall ALS Disability Scale: ROADS to a better ALS outcome measure
    Volume: 94
    04/14/2020 Authors: Fournier C; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski K; Tyor W; Hertzberg V; James V; Polak M
  • Outcomes after stereotactic radiosurgery for CNS lymphoma.
    J Neurooncol Volume: 147 Page(s): 465 - 476
    04/01/2020 Authors: Palmer JD; Bhamidipati D; Shukla G; Epperla N; Glass J; Kim L; Shi W
  • Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
    JAMA Neurol Volume: 77 Page(s): 480 - 488
    04/01/2020 Authors: Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M
  • The gut microbiome and neuroinflammation in amyotrophic lateral sclerosis? Emerging clinical evidence.
    Neurobiol Dis Volume: 135 Page(s): 104300
    02/01/2020 Authors: Fournier CN; Houser M; Tansey MG; Glass JD; Hertzberg VS
  • Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center.
    Asia Pac J Ophthalmol (Phila) Volume: 9 Page(s): 110 - 116
    01/01/2020 Authors: Dalvin LA; Lim L-AS; Ancona-Lezama D; Mazloumi M; Chang M; Porcu P; Martinez NL; Glass J; Mashayekhi A; Shields CL
  • Theme 2 Genetics and genomics.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 20 Page(s): 114 - 134
    11/01/2019 Authors: Roggenbuck J; Doyle C; Lincoln T; Glass J
  • Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidence.
    Muscle Nerve Volume: 60 Page(s): 443 - 452
    10/01/2019 Authors: Dios AM; Babu S; Granucci EJ; Mueller KA; Mills AN; Alshikho MJ; Zrcher NR; Cernasov P; Gilbert TM; Glass JD
  • Distal denervation in the SOD1 knockout mouse correlates with loss of mitochondria at the motor nerve terminal.
    Exp Neurol Volume: 318 Page(s): 251 - 257
    08/01/2019 Authors: Hayes LR; Asress SA; Li Y; Galkin A; Stepanova A; Kawamata H; Manfredi G; Glass JD
  • CpG-related SNPs in the MS4A region have a dose-dependent effect on risk of late-onset Alzheimer disease.
    Aging Cell Volume: 18 Page(s): e12964
    08/01/2019 Authors: Ma Y; Jun GR; Chung J; Zhang X; Kunkle BW; Naj AC; White CC; Bennett DA; De Jager PL; Alzheimers Disease Genetics Consortium
  • Clinical utility of RNA sequencing to resolve unusual GNE myopathy with a novel promoter deletion.
    Muscle Nerve Volume: 60 Page(s): 98 - 103
    07/01/2019 Authors: Chakravorty S; Berger K; Arafat D; Nallamilli BRR; Subramanian HP; Joseph S; Anderson ME; Campbell KP; Glass J; Gibson G
  • Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.
    Acta Neuropathol Volume: 137 Page(s): 879 - 899
    06/01/2019 Authors: Pottier C; Ren Y; Perkerson RB; Baker M; Jenkins GD; van Blitterswijk M; DeJesus-Hernandez M; van Rooij JGJ; Murray ME; Christopher E
  • Dementia in ALS: the role of the cerebellum
    Volume: 78 Page(s): 520 - 521
    06/01/2019 Authors: Lowder L; Asress S; Dammer E; Vizcarra JC; Duc D; Goodman A; Bagchi P; Gearing M; Gutman D; Seyfried N
  • Rapid Early Tumor Progression is Prognostic in Glioblastoma Patients.
    Am J Clin Oncol Volume: 42 Page(s): 481 - 486
    05/01/2019 Authors: Palmer JD; Bhamidipati D; Shukla G; Sharma D; Glass J; Kim L; Evans JJ; Judy K; Farrell C; Andrews DW
  • PRO-ACE: Global Collaborative Ecosystem in a Post-PRO-ACT Era
    Volume: 92
    04/09/2019 Authors: Sherman A; Berry J; Gotkine M; Glass J; Lunetta C; Floeter MK; Traynor B; Katsovskiy I; Kharakozova O; Korin A
  • TDP-43 cytoplasmic inclusion formation in C9orf72-associated FTLD/ALS
    Volume: 92
    04/09/2019 Authors: Lee S; Asress S; Hales C; Vizcarra J; Gutman D; Gearing M; Chin L-S; Li L; Glass J
  • Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis.
    Ann Neurol Volume: 85 Page(s): 470 - 481
    04/01/2019 Authors: Bandres-Ciga S; Noyce AJ; Hemani G; Nicolas A; Calvo A; Mora G; ITALSGEN Consortium; International ALS Genomics Consortium; Tienari PJ; Stone DJ
  • Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas.
    Radiother Oncol Volume: 132 Page(s): 135 - 141
    03/01/2019 Authors: Song A; Andrews DW; Werner-Wasik M; Kim L; Glass J; Bar-Ad V; Evans JJ; Farrell CJ; Judy KD; Daskalakis C
  • Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort.
    Neurobiol Aging Volume: 74 Page(s): 234.e9 - 234.e15
    02/01/2019 Authors: Tazelaar GHP; Dekker AM; van Vugt JJFA; van der Spek RA; Westeneng H-J; Kool LJBG; Kenna KP; van Rheenen W; Pulit SL; McLaughlin RL
  • ALSUntangled 46: penicillin G/hydrocortisone
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION Volume: 20 Page(s): 126 - 131
    01/02/2019 Authors: Bedlack R; Crayle J; Armon C; Barkhaus P; Bereman M; Bromberg M; Brooks BR; Carter G; Chen A; Cudkowicz M
  • TDP-43 cytoplasmic inclusion formation is disrupted in C9orf72-associated amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Brain Commun Volume: 1 Page(s): fcz014
    01/01/2019 Authors: Lee SM; Asress S; Hales CM; Gearing M; Vizcarra JC; Fournier CN; Gutman DA; Chin L-S; Li L; Glass JD
  • Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
    J Neurooncol Volume: 140 Page(s): 623 - 628
    12/01/2018 Authors: Palmer JD; Bhamidipati D; Song A; Eldredge-Hindy HB; Siglin J; Dan TD; Champ CE; Zhang I; Bar-Ad V; Kim L
  • Multiple prebiotic metals mediate translation.
    Proc Natl Acad Sci U S A Volume: 115 Page(s): 12164 - 12169
    11/27/2018 Authors: Bray MS; Lenz TK; Haynes JW; Bowman JC; Petrov AS; Reddi AR; Hud NV; Williams LD; Glass JB
  • ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function.
    Neurobiol Aging Volume: 71 Page(s): 266.e1 - 266.e10
    11/01/2018 Authors: de Majo M; Topp SD; Smith BN; Nishimura AL; Chen H-J; Gkazi AS; Miller J; Wong CH; Vance C; Baas F
  • Potential Role of the Gut Microbiome in ALS: A Systematic Review.
    Biol Res Nurs Volume: 20 Page(s): 513 - 521
    10/01/2018 Authors: Wright ML; Fournier C; Houser MC; Tansey M; Glass J; Hertzberg VS
  • Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis.
    Eur J Hum Genet Volume: 26 Page(s): 1537 - 1546
    10/01/2018 Authors: Project MinE ALS Sequencing Consortium
  • Stem cell transplantation for amyotrophic lateral sclerosis.
    Curr Opin Neurol Volume: 31 Page(s): 655 - 661
    10/01/2018 Authors: Baloh RH; Glass JD; Svendsen CN
  • Reader response: Pathologic Thr175 tau phosphorylation in CTE and CTE with ALS.
    Neurology Volume: 91 Page(s): 578 - 579
    09/18/2018 Authors: Glass JD; Fournier CN; Gearing M
  • Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centres.
    Clin Neurophysiol Volume: 129 Page(s): 1756 - 1762
    08/01/2018 Authors: Neuwirth C; Braun N; Claeys KG; Bucelli R; Fournier C; Bromberg M; Petri S; Goedee S; Lenglet T; Leppanen R
  • ALSUntangled 43: copper.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 19 Page(s): 472 - 476
    08/01/2018 Authors: ALSUNTANGLED GROUP
  • CHCHD10 variants in amyotrophic lateral sclerosis: Where is the evidence?
    Ann Neurol Volume: 84 Page(s): 110 - 116
    07/01/2018 Authors: Project MinE ALS Sequencing Consortium
  • Adoptive transfer of IL-10+ regulatory B cells decreases myeloid-derived macrophages in the central nervous system in a transgenic amyotrophic lateral sclerosis model.
    Cell Mol Immunol Volume: 15 Page(s): 727 - 730
    07/01/2018 Authors: Pennati A; Asress S; Glass JD; Galipeau J
  • Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.
    Lancet Neurol Volume: 17 Page(s): 548 - 558
    06/01/2018 Authors: Pottier C; Zhou X; Perkerson RB; Baker M; Jenkins GD; Serie DJ; Ghidoni R; Benussi L; Binetti G; Lpez de Munain A
  • Long-term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS.
    Ann Clin Transl Neurol Volume: 5 Page(s): 730 - 740
    06/01/2018 Authors: Goutman SA; Brown MB; Glass JD; Boulis NM; Johe K; Hazel T; Cudkowicz M; Atassi N; Borges L; Patil PG
  • An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 19 Page(s): 242 - 249
    05/01/2018 Authors: Fournier CN; Schoenfeld D; Berry JD; Cudkowicz ME; Chan J; Quinn C; Brown RH; Salameh JS; Tansey MG; Beers DR
  • Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
    Neuron Volume: 97 Page(s): 1267 - 1288
    03/21/2018 Authors: Nicolas A; Kenna KP; Renton AE; Ticozzi N; Faghri F; Chia R; Dominov JA; Kenna BJ; Nalls MA; Keagle P
  • Protecting the nerve terminals.
    Elife Volume: 7
    03/19/2018 Authors: Glass JD
  • ALSUntangled 41: "Eric Is Winning".
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 19 Page(s): 157 - 160
    02/01/2018 Authors: ALSUntangled Group
  • TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
    Nat Neurosci Volume: 21 Page(s): 228 - 239
    02/01/2018 Authors: Chou C-C; Zhang Y; Umoh ME; Vaughan SW; Lorenzini I; Liu F; Sayegh M; Donlin-Asp PG; Chen YH; Duong DM
  • Reconsidering the causality of TIA1 mutations in ALS.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 19 Page(s): 1 - 3
    02/01/2018 Authors: van der Spek RA; van Rheenen W; Pulit SL; Kenna KP; Ticozzi N; Kooyman M; Mclaughlin RL; Moisse M; van Eijk KR; van Vugt JJFA
  • Improving symptom management for people with amyotrophic lateral sclerosis.
    Muscle Nerve Volume: 57 Page(s): 20 - 24
    01/01/2018 Authors: Nicholson K; Murphy A; McDonnell E; Shapiro J; Simpson E; Glass J; Mitsumoto H; Forshew D; Miller R; Atassi N
  • A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
    EMBO Mol Med Volume: 10 Page(s): 48 - 62
    01/01/2018 Authors: Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
  • Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.
    Mol Neurodegener Volume: 12 Page(s): 76
    10/24/2017 Authors: Konrad C; Kawamata H; Bredvik KG; Arreguin AJ; Cajamarca SA; Hupf JC; Ravits JM; Miller TM; Maragakis NJ; Hales CM
  • Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and phase 2 trials (vol 87, pg 392, 2016)
    NEUROLOGY Volume: 89 Page(s): 521 - 521
    08/01/2017 Authors: Glass JD; Hertzberg VS; Boulis NM
  • Current management of primary central nervous system lymphoma.
    Chin Clin Oncol Volume: 6 Page(s): 38
    08/01/2017 Authors: Glass J
  • Comprehensive analysis to explain reduced or increased SOD1 enzymatic activity in ALS patients and their relatives.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 18 Page(s): 457 - 463
    08/01/2017 Authors: Keskin I; Birve A; Berdynski M; Hjertkvist K; Rofougaran R; Nilsson TK; Glass JD; Marklund SL; Andersen PM
  • Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis.
    Ann Neurol Volume: 82 Page(s): 139 - 146
    07/01/2017 Authors: Gendron TF; C9ORF72 Neurofilament Study Group; Daughrity LM; Heckman MG; Diehl NN; Wuu J; Miller TM; Pastor P; Trojanowski JQ; Grossman M
  • Transethnic genome-wide scan identifies novel Alzheimer's disease loci.
    Alzheimers Dement Volume: 13 Page(s): 727 - 738
    07/01/2017 Authors: Jun GR; Chung J; Mez J; Barber R; Beecham GW; Bennett DA; Buxbaum JD; Byrd GS; Carrasquillo MM; Crane PK
  • Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.
    JAMA Oncol Volume: 3 Page(s): 784 - 792
    06/01/2017 Authors: Bell EH; Pugh SL; McElroy JP; Gilbert MR; Mehta M; Klimowicz AC; Magliocco A; Bredel M; Robe P; Grosu A-L
  • Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis.
    Sci Transl Med Volume: 9
    05/03/2017 Authors: Smith BN; Topp SD; Fallini C; Shibata H; Chen H-J; Troakes C; King A; Ticozzi N; Kenna KP; Soragia-Gkazi A
  • ALSUntangled No. 37: Inosine.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 18 Page(s): 309 - 312
    05/01/2017 Authors: ALSUntangled Group
  • Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis.
    Sci Transl Med Volume: 9
    03/29/2017 Authors: Gendron TF; Chew J; Stankowski JN; Hayes LR; Zhang Y-J; Prudencio M; Carlomagno Y; Daughrity LM; Jansen-West K; Perkerson EA
  • Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.
    Nat Commun Volume: 8 Page(s): 14774
    03/21/2017 Authors: McLaughlin RL; Schijven D; van Rheenen W; van Eijk KR; O'Brien M; Kahn RS; Ophoff RA; Goris A; Bradley DG; Al-Chalabi A
  • ALSUntangled No. 36: Accilion.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 18 Page(s): 142 - 147
    02/01/2017 Authors: ALSUNTANGLED GROUP
  • ALSUntangled 38: L-serine.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 18 Page(s): 148 - 151
    02/01/2017 Authors: ALSUntangled Group
  • Defining SOD1 ALS natural history to guide therapeutic clinical trial design.
    J Neurol Neurosurg Psychiatry Volume: 88 Page(s): 99 - 105
    02/01/2017 Authors: Bali T; Self W; Liu J; Siddique T; Wang LH; Bird TD; Ratti E; Atassi N; Boylan KB; Glass JD
  • A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.
    Cell Syst Volume: 4 Page(s): 60 - 72.e4
    01/25/2017 Authors: Seyfried NT; Dammer EB; Swarup V; Nandakumar D; Duong DM; Yin L; Deng Q; Nguyen T; Hales CM; Wingo T
  • Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS.
    Acta Neuropathol Volume: 132 Page(s): 827 - 840
    12/01/2016 Authors: Ayers JI; Diamond J; Sari A; Fromholt S; Galaleldeen A; Ostrow LW; Glass JD; Hart PJ; Borchelt DR
  • Reply to M.C. Chamberlain.
    J Clin Oncol Volume: 34 Page(s): 4057
    11/20/2016 Authors: Glass J; Werner-Wasik M; Mehta MP
  • Predicting disease progression in amyotrophic lateral sclerosis.
    Ann Clin Transl Neurol Volume: 3 Page(s): 866 - 875
    11/01/2016 Authors: Taylor AA; Fournier C; Polak M; Wang L; Zach N; Keymer M; Glass JD; Ennist DL; Pooled Resource OpenAccess ALS Clinical Trials Consortium
  • Estimating the palliative effect of percutaneous endoscopic gastrostomy in an observational registry using principal stratification and generalized propensity scores.
    Sci Rep Volume: 6 Page(s): 33431
    09/19/2016 Authors: Mishra-Kalyani PS; Johnson BA; Glass JD; Long Q
  • Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population.
    Neurology Volume: 87 Page(s): 1024 - 1030
    09/06/2016 Authors: Umoh ME; Fournier C; Li Y; Polak M; Shaw L; Landers JE; Hu W; Gearing M; Glass JD
  • NEK1 variants confer susceptibility to amyotrophic lateral sclerosis.
    Nat Genet Volume: 48 Page(s): 1037 - 1042
    09/01/2016 Authors: Kenna KP; van Doormaal PTC; Dekker AM; Ticozzi N; Kenna BJ; Diekstra FP; van Rheenen W; van Eijk KR; Jones AR; Keagle P
  • Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.
    Nat Genet Volume: 48 Page(s): 1043 - 1048
    09/01/2016 Authors: van Rheenen W; Shatunov A; Dekker AM; McLaughlin RL; Diekstra FP; Pulit SL; van der Spek RAA; Vsa U; de Jong S; Robinson MR
  • The Astrobiology Primer v2.0.
    Astrobiology Volume: 16 Page(s): 561 - 653
    08/01/2016 Authors: Domagal-Goldman SD; Wright KE; Adamala K; Arina de la Rubia L; Bond J; Dartnell LR; Goldman AD; Lynch K; Naud M-E; Paulino-Lima IG
  • Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trials.
    Neurology Volume: 87 Page(s): 392 - 400
    07/26/2016 Authors: Glass JD; Hertzberg VS; Boulis NM; Riley J; Federici T; Polak M; Bordeau J; Fournier C; Johe K; Hazel T
  • Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis.
    JAMA Neurol Volume: 73 Page(s): 812 - 820
    07/01/2016 Authors: Fogh I; Lin K; Tiloca C; Rooney J; Gellera C; Diekstra FP; Ratti A; Shatunov A; van Es MA; Proitsi P
  • Applicability of digital analysis and imaging technology in neuropathology assessment.
    Neuropathology Volume: 36 Page(s): 270 - 282
    06/01/2016 Authors: Dunn WD; Gearing M; Park Y; Zhang L; Hanfelt J; Glass JD; Gutman DA
  • A Case of Adult-Onset Leukoencephalopathy with Spheroids and Pigmented Glia
    Volume: 75 Page(s): 603 - 603
    06/01/2016 Authors: Vega JV; Neill S; Schniederjan M; Hunter S; Glass J; Gearing M
  • Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas.
    J Neurooncol Volume: 127 Page(s): 535 - 539
    05/01/2016 Authors: Shi W; Palmer JD; Werner-Wasik M; Andrews DW; Evans JJ; Glass J; Kim L; Bar-Ad V; Judy K; Farrell C
  • Calming the excitement in ALS.
    Neurology Volume: 86 Page(s): 1468 - 1469
    04/19/2016 Authors: Glass JD
  • CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia.
    Nat Commun Volume: 7 Page(s): 11253
    04/15/2016 Authors: Williams KL; Topp S; Yang S; Smith B; Fifita JA; Warraich ST; Zhang KY; Farrawell N; Vance C; Hu X
  • The Evaluation and Management of Alternative Diagnoses in Amyotrophic Lateral Sclerosis
    Volume: 86
    04/05/2016 Authors: Kannan M; Glass J
  • Survival and Disease Progression in SOD1 Familial ALS in North America
    Volume: 86
    04/05/2016 Authors: Bali T; Self W; Siddique T; Wang L; Ratti E; Boylan K; Glass J; Maragakis N; Caress J; Scherer S
  • The Evaluation and Management of Alternative Diagnoses in Amyotrophic Lateral Sclerosis
    Volume: 86
    04/05/2016 Authors: Kannan M; Glass J
  • A novel Alzheimer disease locus located near the gene encoding tau protein.
    Mol Psychiatry Volume: 21 Page(s): 108 - 117
    01/01/2016 Authors: Jun G; Ibrahim-Verbaas CA; Vronskaya M; Lambert J-C; Chung J; Naj AC; Kunkle BW; Wang L-S; Bis JC; Bellenguez C
  • Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.
    PLoS One Volume: 11 Page(s): e0148717
    01/01/2016 Authors: Karch CM; Ezerskiy LA; Bertelsen S; Alzheimers Disease Genetics Consortium (ADGC); Goate AM
  • The Shreveport Myeloma Experience: Survival, Risk Factors and Other Malignancies in the Age of Stem Cell Transplantation.
    Acta Haematol Volume: 135 Page(s): 146 - 155
    01/01/2016 Authors: Munker R; Shi R; Nair B; Devarakonda S; Cotelingam JD; McLarty J; Mills GM; Glass J
  • 2-Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS).
    Neurobiol Dis Volume: 85 Page(s): 11 - 24
    01/01/2016 Authors: Bartus RT; Btourn A; Basile A; Peterson BL; Glass J; Boulis NM
  • ALSUntangled No. 35: Hyperbaric Oxygen Therapy.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 17 Page(s): 622 - 624
    01/01/2016 Authors: ALSUntangled Group
  • ALSUntangled No. 34: GM604.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 17 Page(s): 617 - 621
    01/01/2016
  • Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.
    Alzheimers Dement Volume: 11 Page(s): 1439 - 1451
    12/01/2015 Authors: Mukherjee S; Walter S; Kauwe JSK; Saykin AJ; Bennett DA; Larson EB; Crane PK; Glymour MM; Adult Changes in Thought Study Investigators; Religious Orders Study/Memory and Aging Project Investigators
  • Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.
    J Neurooncol Volume: 124 Page(s): 215 - 221
    09/01/2015 Authors: Palmer JD; Siglin J; Yamoah K; Dan T; Champ CE; Bar-Ad V; Werner-Wasik M; Evans JJ; Kim L; Glass J
  • Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study.
    PLoS Med Volume: 12 Page(s): e1001841
    06/01/2015 Authors: stergaard SD; Mukherjee S; Sharp SJ; Proitsi P; Lotta LA; Day F; Perry JRB; Boehme KL; Walter S; Kauwe JS
  • Head injury does not alter disease progression or neuropathologic outcomes in ALS.
    Neurology Volume: 84 Page(s): 1788 - 1795
    04/28/2015 Authors: Fournier CN; Gearing M; Upadhyayula SR; Klein M; Glass JD
  • Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.
    Science Volume: 347 Page(s): 1436 - 1441
    03/27/2015 Authors: Cirulli ET; Lasseigne BN; Petrovski S; Sapp PC; Dion PA; Leblond CS; Couthouis J; Lu Y-F; Wang Q; Krueger BJ
  • ALSUntangled: introducing The Table of Evidence.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 16 Page(s): 142 - 145
    03/01/2015 Authors: ALSUntangled Group
  • Rarity of the Alzheimer disease-protective APP A673T variant in the United States.
    JAMA Neurol Volume: 72 Page(s): 209 - 216
    02/01/2015 Authors: Wang L-S; Naj AC; Graham RR; Crane PK; Kunkle BW; Cruchaga C; Murcia JDG; Cannon-Albright L; Baldwin CT; Zetterberg H
  • CSF beta-amyloid 1-42 - what are we measuring in Alzheimer's disease?
    Ann Clin Transl Neurol Volume: 2 Page(s): 131 - 139
    02/01/2015 Authors: Hu WT; Watts KD; Shaw LM; Howell JC; Trojanowski JQ; Basra S; Glass JD; Lah JJ; Levey AI
  • Human neural stem cell transplantation in ALS: initial results from a phase I trial.
    J Transl Med Volume: 13 Page(s): 17
    01/27/2015 Authors: Mazzini L; Gelati M; Profico DC; Sgaravizzi G; Projetti Pensi M; Muzi G; Ricciolini C; Rota Nodari L; Carletti S; Giorgi C
  • ALSUntangled No. 29: MitoQ.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 16 Page(s): 427 - 429
    01/01/2015 Authors: ALSUntangled Group
  • Modeling the course of amyotrophic lateral sclerosis.
    Nat Biotechnol Volume: 33 Page(s): 45 - 47
    01/01/2015 Authors: Fournier C; Glass JD
  • Antecedent Disease is Less Prevalent in Amyotrophic Lateral Sclerosis.
    Neurodegener Dis Volume: 15 Page(s): 109 - 113
    01/01/2015 Authors: Mitchell CS; Hollinger SK; Goswami SD; Polak MA; Lee RH; Glass JD
  • Late-stage CTE pathology in a retired soccer player with dementia.
    Neurology Volume: 83 Page(s): 2307 - 2309
    12/09/2014 Authors: Hales C; Neill S; Gearing M; Cooper D; Glass J; Lah J
  • ALSUntangled No. 26: lunasin.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 15 Page(s): 622 - 626
    12/01/2014 Authors: ALSUntangled Group
  • Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.
    JAMA Neurol Volume: 71 Page(s): 1394 - 1404
    11/01/2014 Authors: Naj AC; Jun G; Reitz C; Kunkle BW; Perry W; Park YS; Beecham GW; Rajbhandary RA; Hamilton-Nelson KL; Wang L-S
  • Analysis of graft survival in a trial of stem cell transplant in ALS.
    Ann Clin Transl Neurol Volume: 1 Page(s): 900 - 908
    11/01/2014 Authors: Tadesse T; Gearing M; Senitzer D; Saxe D; Brat DJ; Bray R; Gebel H; Hill C; Boulis N; Riley J
  • Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.
    Lancet Neurol Volume: 13 Page(s): 1083 - 1091
    11/01/2014 Authors: Cudkowicz ME; Titus S; Kearney M; Yu H; Sherman A; Schoenfeld D; Hayden D; Shui A; Brooks B; Conwit R
  • Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS.
    Neuron Volume: 84 Page(s): 324 - 331
    10/22/2014 Authors: Smith BN; Ticozzi N; Fallini C; Gkazi AS; Topp S; Kenna KP; Scotter EL; Kost J; Keagle P; Miller JW
  • Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis.
    J Clin Pharmacol Volume: 54 Page(s): 1180 - 1187
    10/01/2014 Authors: Zhao Y; Cudkowicz ME; Shefner JM; Krivickas L; David WS; Vriesendorp F; Pestronk A; Caress JB; Katz J; Simpson E
  • Seeking a measure of clinically meaningful change in ALS.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 15 Page(s): 398 - 405
    09/01/2014 Authors: McElhiney M; Rabkin JG; Goetz R; Katz J; Miller RG; Forshew DA; David W; Cudkowicz M; Glass JD; Appel S
  • Aggregates of small nuclear ribonucleic acids (snRNAs) in Alzheimer's disease.
    Brain Pathol Volume: 24 Page(s): 344 - 351
    07/01/2014 Authors: Hales CM; Dammer EB; Diner I; Yi H; Seyfried NT; Gearing M; Glass JD; Montine TJ; Levey AI; Lah JJ
  • Loss of dopamine phenotype among midbrain neurons in Lesch-Nyhan disease.
    Ann Neurol Volume: 76 Page(s): 95 - 107
    07/01/2014 Authors: Gttle M; Prudente CN; Fu R; Sutcliffe D; Pang H; Cooper D; Veledar E; Glass JD; Gearing M; Visser JE
  • Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.
    Lancet Volume: 383 Page(s): 2065 - 2072
    06/14/2014 Authors: Wills A-M; Hubbard J; Macklin EA; Glass J; Tandan R; Simpson EP; Brooks B; Gelinas D; Mitsumoto H; Mozaffar T
  • 3R Predominant Tauopathy with Globular Glial Inclusions
    Volume: 73 Page(s): 624 - 624
    06/01/2014 Authors: Neill S; Glass J; Levey A; Parker M; Cooper D; Gearing M
  • A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis.
    Hum Mol Genet Volume: 23 Page(s): 2220 - 2231
    04/15/2014 Authors: Fogh I; Ratti A; Gellera C; Lin K; Tiloca C; Moskvina V; Corrado L; Sorar G; Cereda C; Corti S
  • Activated 5'flanking region of NANOGP8 in a self-renewal environment is associated with increased sphere formation and tumor growth of prostate cancer cells.
    Prostate Volume: 74 Page(s): 381 - 394
    04/01/2014 Authors: Zhang K; Fowler M; Glass J; Yin H
  • Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes.
    Ann Neurol Volume: 75 Page(s): 363 - 373
    03/01/2014 Authors: Feldman EL; Boulis NM; Hur J; Johe K; Rutkove SB; Federici T; Polak M; Bordeau J; Sakowski SA; Glass JD
  • Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme.
    J Neurooncol Volume: 117 Page(s): 125 - 131
    03/01/2014 Authors: Champ CE; Palmer JD; Volek JS; Werner-Wasik M; Andrews DW; Evans JJ; Glass J; Kim L; Shi W
  • Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes.
    Neurosurgery Volume: 74 Page(s): 77 - 87
    01/01/2014 Authors: Riley J; Glass J; Feldman EL; Polak M; Bordeau J; Federici T; Johe K; Boulis NM
  • Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP.
    Neurology Volume: 81 Page(s): 1945 - 1952
    11/26/2013 Authors: Hu WT; Watts K; Grossman M; Glass J; Lah JJ; Hales C; Shelnutt M; Van Deerlin V; Trojanowski JQ; Levey AI
  • Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011.
    Neurol Clin Pract Volume: 3 Page(s): 313 - 320
    08/01/2013 Authors: Traxinger K; Kelly C; Johnson BA; Lyles RH; Glass JD
  • Axonal degeneration in the peripheral nervous system: implications for the pathogenesis of amyotrophic lateral sclerosis.
    Exp Neurol Volume: 246 Page(s): 6 - 13
    08/01/2013 Authors: Fischer-Hayes LR; Brotherton T; Glass JD
  • Exome sequencing to identify de novo mutations in sporadic ALS trios.
    Nat Neurosci Volume: 16 Page(s): 851 - 855
    07/01/2013 Authors: Chesi A; Staahl BT; Jovii A; Couthouis J; Fasolino M; Raphael AR; Yamazaki T; Elias L; Polak M; Kelly C
  • A 60-year-old Indian male with altered sensorium and extensive lymphoma of the scalp.
    Semin Oncol Volume: 40 Page(s): e9 - 21
    06/01/2013 Authors: Yadav BS; Bansal A; Sharma SC; Malhotra P; Ghosh N; Holdhoff M; Shustov A; Chamberlain M; Newton H; Kumethkar P
  • Motor and sensory neuropathy due to myelin infolding and paranodal damage in a transgenic mouse model of Charcot-Marie-Tooth disease type 1C.
    Hum Mol Genet Volume: 22 Page(s): 1755 - 1770
    05/01/2013 Authors: Lee SM; Sha D; Mohammed AA; Asress S; Glass JD; Chin L-S; Li L
  • ALS Untangled No. 20: the Deanna protocol.
    Amyotroph Lateral Scler Frontotemporal Degener Volume: 14 Page(s): 319 - 323
    05/01/2013 Authors: ALSUntangled Group; Fournier C; Bedlack B; Hardiman O; Heiman-Patterson T; Gutmann L; Bromberg M; Ostrow L; Carter G; Kabashi E
  • Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    J Neurol Neurosurg Psychiatry Volume: 84 Page(s): 467 - 472
    04/01/2013 Authors: Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M
  • The spatial relationship between neurons and astrocytes in HIV-associated dementia.
    J Neurovirol Volume: 19 Page(s): 123 - 130
    04/01/2013 Authors: Roberts ES; Chana G; Nguyen TB; Perera G; Landau S; Rabe-Hesketh S; Glass JD; McArthur J; Everall IP
  • TDP-43 Inclusions in the Spinal Cord: Sensitivity and Specificity for the Diagnosis of Sporadic ALS
    Volume: 80
    02/12/2013 Authors: Upadhyayula S; Gearing M; Glass J
  • Cellular toxicity of mutant SOD1 protein is linked to an easily soluble, non-aggregated form in vitro.
    Neurobiol Dis Volume: 49 Page(s): 49 - 56
    01/01/2013 Authors: Brotherton TE; Li Y; Glass JD
  • Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis.
    PLoS One Volume: 8 Page(s): e61177
    01/01/2013 Authors: Berry JD; Shefner JM; Conwit R; Schoenfeld D; Keroack M; Felsenstein D; Krivickas L; David WS; Vriesendorp F; Pestronk A
  • Behavior matters--cognitive predictors of survival in amyotrophic lateral sclerosis.
    PLoS One Volume: 8 Page(s): e57584
    01/01/2013 Authors: Hu WT; Shelnutt M; Wilson A; Yarab N; Kelly C; Grossman M; Libon DJ; Khan J; Lah JJ; Levey AI
  • Commercial insurance triples chances of breast cancer survival in a public hospital.
    Breast J Volume: 19 Page(s): 664 - 667
    01/01/2013 Authors: Shi R; Mills G; McLarty J; Burton G; Shi Z; Glass J
  • Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis.
    Nat Genet Volume: 44 Page(s): 1349 - 1354
    12/01/2012 Authors: Whitcomb DC; LaRusch J; Krasinskas AM; Klei L; Smith JP; Brand RE; Neoptolemos JP; Lerch MM; Tector M; Sandhu BS
  • The ultimate question: why do axons degenerate? A tribute to the work and mentorship of John W. Griffin, MD.
    J Peripher Nerv Syst Volume: 17 Suppl 3 Page(s): 24 - 29
    12/01/2012 Authors: Glass JD
  • ALS untangled No. 17: "when ALS is lyme".
    Amyotroph Lateral Scler Volume: 13 Page(s): 487 - 491
    09/01/2012 Authors: ALSUntangled Group
  • Improving prognosis of glioblastoma in the 21st century: who has benefited most?
    Cancer Volume: 118 Page(s): 4228 - 4234
    09/01/2012 Authors: Lawrence YR; Mishra MV; Werner-Wasik M; Andrews DW; Showalter TN; Glass J; Shen X; Symon Z; Dicker AP
  • Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis.
    Nature Volume: 488 Page(s): 499 - 503
    08/23/2012 Authors: Wu C-H; Fallini C; Ticozzi N; Keagle PJ; Sapp PC; Piotrowska K; Lowe P; Koppers M; McKenna-Yasek D; Baron DM
  • Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
    Hum Mol Genet Volume: 21 Page(s): 3500 - 3512
    08/01/2012 Authors: Coppola G; Chinnathambi S; Lee JJ; Dombroski BA; Baker MC; Soto-Ortolaza AI; Lee SE; Klein E; Huang AY; Sears R
  • Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes.
    Neurosurgery Volume: 71 Page(s): 405 - 416
    08/01/2012 Authors: Riley J; Federici T; Polak M; Kelly C; Glass J; Raore B; Taub J; Kesner V; Feldman EL; Boulis NM
  • ALSUntangled No. 16: cannabis.
    Amyotroph Lateral Scler Volume: 13 Page(s): 400 - 404
    06/01/2012 Authors: ALSUntangled Group
  • Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients.
    Stem Cells Volume: 30 Page(s): 1144 - 1151
    06/01/2012 Authors: Glass JD; Boulis NM; Johe K; Rutkove SB; Federici T; Polak M; Kelly C; Feldman EL
  • Neuronal TDP-43-Positive Inclusions in the Spinal Cord Distinguish ALS from FTLD-TDP
    Volume: 71 Page(s): 590 - 590
    06/01/2012 Authors: Gearing M; Cooper D; Glass J
  • Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards.
    J Proteome Res Volume: 11 Page(s): 2721 - 2738
    05/04/2012 Authors: Seyfried NT; Gozal YM; Donovan LE; Herskowitz JH; Dammer EB; Xia Q; Ku L; Chang J; Duong DM; Rees HD
  • ALSUntangled 15: coconut Oil.
    Amyotroph Lateral Scler Volume: 13 Page(s): 328 - 330
    05/01/2012 Authors: ALSUntangled Group
  • Characterization and outcomes of optic nerve gliomas: a population-based analysis.
    J Neurooncol Volume: 107 Page(s): 591 - 597
    05/01/2012 Authors: Mishra MV; Andrews DW; Glass J; Evans JJ; Dicker AP; Shen X; Lawrence YR
  • Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS.
    Proc Natl Acad Sci U S A Volume: 109 Page(s): 5505 - 5510
    04/03/2012 Authors: Brotherton TE; Li Y; Cooper D; Gearing M; Julien J-P; Rothstein JD; Boylan K; Glass JD
  • A 61-year-old woman with progressive weakness and rash.
    Neurohospitalist Volume: 2 Page(s): 62 - 65
    04/01/2012 Authors: Anderson ER; Glass JD; Greene JG
  • Cerebrospinal Fluid beta-Amyloid 1-42 Solubility Is Influenced by Apolipoproteins E and J
    Volume: 78
    04/01/2012 Authors: Hu W; Basra S; Watts K; Glass J; Lah J; Levey A
  • Iron facilitator LS081 reduces hypoxia-inducible factor-1 protein and functions as anticancer agent in hepatocellular carcinoma.
    Cancer Sci Volume: 103 Page(s): 767 - 774
    04/01/2012 Authors: Tanaka H; Li Z; Ikuta K; Addo L; Akutsu H; Nakamura M; Sasaki K; Ohtake T; Fujiya M; Torimoto Y
  • Dusty: an assistive mobile manipulator that retrieves dropped objects for people with motor impairments.
    Disabil Rehabil Assist Technol Volume: 7 Page(s): 168 - 179
    03/01/2012 Authors: King C-H; Chen TL; Fan Z; Glass JD; Kemp CC
  • Polymorphisms in the GluR2 gene are not associated with amyotrophic lateral sclerosis.
    Neurobiol Aging Volume: 33 Page(s): 418 - 420
    02/01/2012 Authors: Bogaert E; Goris A; Van Damme P; Geelen V; Lemmens R; van Es MA; van den Berg LH; Sleegers K; Verpoorten N; Timmerman V
  • Absence of SOD1 leads to oxidative stress in peripheral nerve and causes a progressive distal motor axonopathy.
    Exp Neurol Volume: 233 Page(s): 163 - 171
    01/01/2012 Authors: Fischer LR; Li Y; Asress SA; Jones DP; Glass JD
  • Completion and Outcomes of a Phase 1 Intraspinal Stem Cell Transplantation Trial for ALS
    Volume: 72 Page(s): S127 - S128
    01/01/2012 Authors: Feldman EL; Boulis NM; Johe K; Rutkove SB; Federici T; Polak M; Kelly C; Glass JD
  • New drugs for ALS: how do we get there?
    Exp Neurol Volume: 233 Page(s): 112 - 117
    01/01/2012 Authors: Glass JD
  • Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS.
    Amyotroph Lateral Scler Volume: 13 Page(s): 1 - 10
    01/01/2012 Authors: Otto M; Bowser R; Turner M; Berry J; Brettschneider J; Connor J; Costa J; Cudkowicz M; Glass J; Jahn O
  • Translational stem cell therapy for amyotrophic lateral sclerosis.
    Nat Rev Neurol Volume: 8 Page(s): 172 - 176
    12/13/2011 Authors: Boulis NM; Federici T; Glass JD; Lunn JS; Sakowski SA; Feldman EL
  • Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration.
    Mol Neurodegener Volume: 6 Page(s): 82
    11/29/2011 Authors: Gozal YM; Seyfried NT; Gearing M; Glass JD; Heilman CJ; Wuu J; Duong DM; Cheng D; Xia Q; Rees HD
  • In vivo pathogenic role of mutant SOD1 localized in the mitochondrial intermembrane space.
    J Neurosci Volume: 31 Page(s): 15826 - 15837
    11/02/2011 Authors: Igoudjil A; Magran J; Fischer LR; Kim HJ; Hervias I; Dumont M; Cortez C; Glass JD; Starkov AA; Manfredi G
  • First in Human Phase 1 Trial of Neural Progenitor Cells in ALS: Results in the First 12 Patients
    Volume: 70 Page(s): S86 - S86
    10/01/2011 Authors: Glass JD; Boulis N; Polak M; Kelly C; Federici T; Bordeau J; Rutkove S; Johe K; Hazel T; Feldman E
  • Virtual Demyelination in pmp22 Deficiency
    Volume: 70 Page(s): S86 - S86
    10/01/2011 Authors: Glass JD; Boulis N; Polak M; Kelly C; Federici T; Bordeau J; Rutkove S; Johe K; Hazel T; Feldman E
  • Hypoxia-inducible factor-2 and iron absorptive gene expression in Belgrade rat intestine.
    Am J Physiol Gastrointest Liver Physiol Volume: 301 Page(s): G82 - G90
    07/01/2011 Authors: Yeh K-Y; Yeh M; Polk P; Glass J
  • Regenerative Medicine (vol 6, pg 201, 2011)
    REGENERATIVE MEDICINE Volume: 6 Page(s): 536 - 536
    07/01/2011 Authors: Lunn JS; Sakowski SA; Federici T; Glass JD; Boulis NM; Feldman EL
  • The Spectrum of Neuropathology in Patients Dying With Amyotrophic Lateral Sclerosis (ALS) - A Clinicopathologic Study
    Volume: 70 Page(s): 531 - 531
    06/01/2011 Authors: Gearing M; Cooper D; Costa N; Glass J
  • A novel ALS SOD1 C6S mutation with implications for aggregation related toxicity and genetic counseling.
    Amyotroph Lateral Scler Volume: 12 Page(s): 215 - 219
    05/01/2011 Authors: Brotherton T; Polak M; Kelly C; Birve A; Andersen P; Marklund SL; Glass JD
  • Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
    Nat Genet Volume: 43 Page(s): 436 - 441
    05/01/2011 Authors: Naj AC; Jun G; Beecham GW; Wang L-S; Vardarajan BN; Buros J; Gallins PJ; Buxbaum JD; Jarvik GP; Crane PK
  • Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis.
    Am J Med Genet B Neuropsychiatr Genet Volume: 156B Page(s): 285 - 290
    04/01/2011 Authors: Ticozzi N; Vance C; Leclerc AL; Keagle P; Glass JD; McKenna-Yasek D; Sapp PC; Silani V; Bosco DA; Shaw CE
  • Anticancer activity of the iron facilitator LS081.
    J Exp Clin Cancer Res Volume: 30 Page(s): 34
    03/31/2011 Authors: Li Z; Tanaka H; Galiano F; Glass J
  • Intraoperative Evoked Potentials for Monitoring Spinal Cord Stem Cell Injection in Patients with ALS
    Volume: 76 Page(s): A567 - A568
    03/01/2011 Authors: Kesner VG; Glass JD; Feldman E; Boulis N
  • Stem cell technology for the study and treatment of motor neuron diseases.
    Regen Med Volume: 6 Page(s): 201 - 213
    03/01/2011 Authors: Lunn JS; Sakowski SA; Federici T; Glass JD; Boulis NM; Feldman EL
  • The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry.
    PLoS One Volume: 6 Page(s): e27985
    01/01/2011 Authors: Wingo TS; Cutler DJ; Yarab N; Kelly CM; Glass JD
  • SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse.
    Brain Volume: 134 Page(s): 196 - 209
    01/01/2011 Authors: Fischer LR; Igoudjil A; Magran J; Li Y; Hansen JM; Manfredi G; Glass JD
  • First-in-Human Spinal Cord Neural Stem Cell Transplantation Trial: Current Status
    Volume: 20 Page(s): 554 - 555
    01/01/2011 Authors: Federici T; Johe K; Feldman E; Glass J; Boulis N
  • Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma.
    Head Neck Volume: 32 Page(s): 1619 - 1628
    12/01/2010 Authors: Ekshyyan O; Mills GM; Lian T; Amirghahari N; Rong X; Lowery-Nordberg M; Abreo F; Veillon DM; Caldito G; Speicher L
  • Novel Three- and Four-Drug Combination Regimens of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Previously Untreated Multiple Myeloma: Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study
    Volume: 116 Page(s): 273 - 273
    11/19/2010 Authors: Kumar S; Flinn IW; Richardson PG; Hari P; Callander NS; Noga SJ; Stewart AK; Glass J; Rifkin RM; Wolf JL
  • Association of core-binding factor with the malignant phenotype of prostate and ovarian cancer cells.
    J Cell Physiol Volume: 225 Page(s): 875 - 887
    11/01/2010 Authors: Davis JN; Rogers D; Adams L; Yong T; Jung JS; Cheng B; Fennell K; Borazanci E; Moustafa YW; Sun A
  • Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach.
    J Proteome Res Volume: 9 Page(s): 5133 - 5141
    10/01/2010 Authors: Zhou J-Y; Afjehi-Sadat L; Asress S; Duong DM; Cudkowicz M; Glass JD; Peng J
  • Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study.
    Lancet Neurol Volume: 9 Page(s): 986 - 994
    10/01/2010 Authors: Shatunov A; Mok K; Newhouse S; Weale ME; Smith B; Vance C; Johnson L; Veldink JH; van Es MA; van den Berg LH
  • Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitors.
    J Med Chem Volume: 53 Page(s): 6326 - 6336
    09/09/2010 Authors: Ovat A; Li ZZ; Hampton CY; Asress SA; Fernndez FM; Glass JD; Powers JC
  • Paraoxonase gene mutations in amyotrophic lateral sclerosis.
    Ann Neurol Volume: 68 Page(s): 102 - 107
    07/01/2010 Authors: Ticozzi N; LeClerc AL; Keagle PJ; Glass JD; Wills A-M; van Blitterswijk M; Bosco DA; Rodriguez-Leyva I; Gellera C; Ratti A
  • Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.
    J Exp Clin Cancer Res Volume: 29 Page(s): 87
    07/01/2010 Authors: Jafri SH; Glass J; Shi R; Zhang S; Prince M; Kleiner-Hancock H
  • Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study.
    Leukemia Volume: 24 Page(s): 1350 - 1356
    07/01/2010 Authors: Kumar SK; Flinn I; Noga SJ; Hari P; Rifkin R; Callander N; Bhandari M; Wolf JL; Gasparetto C; Krishnan A
  • Toward more efficient clinical trials for amyotrophic lateral sclerosis.
    Amyotroph Lateral Scler Volume: 11 Page(s): 259 - 265
    05/03/2010 Authors: Cudkowicz ME; Katz J; Moore DH; O'Neill G; Glass JD; Mitsumoto H; Appel S; Ravina B; Kieburtz K; Shoulson I
  • Impact of race and ethnicity on outcomes for estrogen receptor-negative breast cancers: experience of an academic center with a charity hospital.
    J Am Coll Surg Volume: 210 Page(s): 585 - 594
    05/01/2010 Authors: Chu QD; Burton G; Glass J; Smith MH; Li BDL
  • Ubisol-Aqua: coenzyme Q10 prevents antiretroviral toxic neuropathy in an in vitro model.
    Curr HIV Res Volume: 8 Page(s): 232 - 239
    04/01/2010 Authors: Cherry CL; Mobarok M; Wesselingh SL; Fain R; Weinstock S; Tachedjian G; Srivastava S; Tyssen DP; Glass JD; Hooker DJ
  • Generalized tetanus despite prior vaccination and a protective level of anti-tetanus antibodies.
    Am J Med Sci Volume: 339 Page(s): 200 - 201
    02/01/2010 Authors: Livorsi DJ; Eaton M; Glass J
  • Oxidative stress induced by loss of Cu,Zn-superoxide dismutase (SOD1) or superoxide-generating herbicides causes axonal degeneration in mouse DRG cultures.
    Acta Neuropathol Volume: 119 Page(s): 249 - 259
    02/01/2010 Authors: Fischer LR; Glass JD
  • Findings that hospital factors are surrogate for disparities are misleading.
    J Clin Oncol Volume: 28 Page(s): e56
    02/01/2010 Authors: Chu QD; Glass J
  • Human Fetal Neural Stem Cell Transplantation for ALS: A Phase I Safety Trial
    Volume: 19 Page(s): 338 - 339
    01/01/2010 Authors: Federici T; Riley J; Johe K; Freeman T; Feldman E; Glass J; Boulis N
  • Non-toxic melanoma therapy by a novel tubulin-binding agent.
    Int J Cancer Volume: 126 Page(s): 256 - 265
    01/01/2010 Authors: Aneja R; Asress S; Dhiman N; Awasthi A; Rida PCG; Arora SK; Zhou J; Glass JD; Joshi HC
  • Novel Three- and Four-Drug Combinations of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Newly Diagnosed Multiple Myeloma: Encouraging Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study
    Volume: 114 Page(s): 57 - 58
    11/20/2009 Authors: Kumar S; Flinn IW; Hari PN; Callander N; Noga SJ; Stewart AK; Glass J; Raje N; Rifkin RM; Shi H
  • Priming of immune responses against transporter associated with antigen processing (TAP)-deficient tumours: tumour direct priming.
    Immunology Volume: 128 Page(s): 420 - 428
    11/01/2009 Authors: Li X-L; Zhang D; Knight D; Odaka Y; Glass J; Mathis JM; Zhang Q-J
  • The APCs of neuroprotection.
    J Clin Invest Volume: 119 Page(s): 3205 - 3207
    11/01/2009 Authors: Esmon CT; Glass JD
  • Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis.
    Nat Genet Volume: 41 Page(s): 1083 - 1087
    10/01/2009 Authors: van Es MA; Veldink JH; Saris CGJ; Blauw HM; van Vught PWJ; Birve A; Lemmens R; Schelhaas HJ; Groen EJN; Huisman MHB
  • Race/Ethnicity has no effect on outcome for breast cancer patients treated at an academic center with a public hospital.
    Cancer Epidemiol Biomarkers Prev Volume: 18 Page(s): 2157 - 2161
    08/01/2009 Authors: Chu QD; Smith MH; Williams M; Panu L; Johnson LW; Shi R; Li BDL; Glass J
  • Effect of B7.1 costimulation on T-cell based immunity against TAP-negative cancer can be facilitated by TAP1 expression.
    PLoS One Volume: 4 Page(s): e6385
    07/24/2009 Authors: Li X-L; Liu Y-Y; Knight D; Odaka Y; Mathis JM; Shi R; Glass J; Zhang Q-J
  • MECHANISM OF AXONAL DEGENERATION IN PACLITAXEL INDUCED NEUROPATHY
    Volume: 14 Page(s): 34 - 34
    07/01/2009 Authors: Clifford K; Melli G; Cavaletti G; Glass J; Hoeke A
  • Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.
    Proc Natl Acad Sci U S A Volume: 106 Page(s): 9004 - 9009
    06/02/2009 Authors: Landers JE; Melki J; Meininger V; Glass JD; van den Berg LH; van Es MA; Sapp PC; van Vught PWJ; McKenna-Yasek DM; Blauw HM
  • Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats.
    J Clin Invest Volume: 119 Page(s): 1150 - 1158
    05/01/2009 Authors: Novak KR; Nardelli P; Cope TC; Filatov G; Glass JD; Khan J; Rich MM
  • Bortezomib, Dexamethasone, Cyclophosphamide, Lenalidomide (VDCR) Has High Efficacy in First-Line MM
    CLINICAL LYMPHOMA & MYELOMA Volume: 9 Page(s): S43 - S44
    02/01/2009 Authors: Kumar S; Flinn I; Noga S; Hari R; Rifkin R; Callander N; Bhandari M; Wolf J; Gasparetto C; Krishnan A
  • Motor Axonopathy in the SOD1 Knockout: A Model of Axonal Degeneration Caused by Oxidative Stress
    Volume: 66 Page(s): S17 - S18
    01/01/2009 Authors: Fischer LR; Glass JD
  • Hand It Over or Set It Down: A User Study of Object Delivery with an Assistive Mobile Manipulator
    Page(s): 602 - 609
    01/01/2009 Authors: Choi YS; Chen T; Jain A; Anderson C; Glass JD; Kemp CC
  • Iron feeding induces ferroportin 1 and hephaestin migration and interaction in rat duodenal epithelium.
    Am J Physiol Gastrointest Liver Physiol Volume: 296 Page(s): G55 - G65
    01/01/2009 Authors: Yeh K-Y; Yeh M; Mims L; Glass J
  • Alzheimer research forum live discussion: mice on trial? Issues in the design of drug studies.
    J Alzheimers Dis Volume: 16 Page(s): 197 - 205
    01/01/2009
  • Subcutaneous IGF-1 is not beneficial in 2-year ALS trial.
    Neurology Volume: 71 Page(s): 1770 - 1775
    11/25/2008 Authors: Sorenson EJ; Windbank AJ; Mandrekar JN; Bamlet WR; Appel SH; Armon C; Barkhaus PE; Bosch P; Boylan K; David WS
  • Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II MultiCenter EVOLUTION Study
    Volume: 112 Page(s): 41 - 42
    11/16/2008 Authors: Kumar S; Flinn IW; Noga SJ; Hari P; Rifkin RM; Callander NS; Bhandari M; Wolf JL; Gasparetto C; Krishnan A
  • Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis.
    J Mot Behav Volume: 40 Page(s): 568 - 577
    11/01/2008 Authors: Guillot TS; Asress SA; Richardson JR; Glass JD; Miller GW
  • Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.
    Cancer Chemother Pharmacol Volume: 62 Page(s): 995 - 1007
    11/01/2008 Authors: Callizot N; Andriambeloson E; Glass J; Revel M; Ferro P; Cirillo R; Vitte P-A; Dreano M
  • A common haplotype within the PON1 promoter region is associated with sporadic ALS.
    Amyotroph Lateral Scler Volume: 9 Page(s): 306 - 314
    10/01/2008 Authors: Landers JE; Shi L; Cho T-J; Glass JD; Shaw CE; Leigh PN; Diekstra F; Polak M; Rodriguez-Leyva I; Niemann S
  • Trogocytosis of MHC-I/peptide complexes derived from tumors and infected cells enhances dendritic cell cross-priming and promotes adaptive T cell responses.
    PLoS One Volume: 3 Page(s): e3097
    08/29/2008 Authors: Zhang Q-J; Li X-L; Wang D; Huang X-C; Mathis JM; Duan W-M; Knight D; Shi R; Glass J; Zhang D-Q
  • 50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosis.
    Amyotroph Lateral Scler Volume: 9 Page(s): 229 - 237
    08/01/2008 Authors: Broom WJ; Greenway M; Sadri-Vakili G; Russ C; Auwarter KE; Glajch KE; Dupre N; Swingler RJ; Purcell S; Hayward C
  • Re-evaluation of archival "DLDH" cases for frontotemporal lobar degeneration with ubiquitin inclusions: antigen retrieval is essential
    Volume: 67 Page(s): 513 - 513
    05/01/2008 Authors: Gearing M; Cooper D; Glass J
  • Central nervous system cancers.
    J Natl Compr Canc Netw Volume: 6 Page(s): 456 - 504
    05/01/2008 Authors: Brem SS; Bierman PJ; Black P; Brem H; Chamberlain MC; Chiocca EA; DeAngelis LM; Fenstermaker RA; Friedman A; Gilbert MR
  • RE-EVALUATION OF ARCHIVAL "DLDH" CASES FOR FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN INCLUSIONS: ANTIGEN RETRIEVAL IS ESSENTIAL
    FASEB JOURNAL Volume: 22
    04/01/2008 Authors: Gearing M; Cooper D; Glass J
  • New VAPB deletion variant and exclusion of VAPB mutations in familial ALS.
    Neurology Volume: 70 Page(s): 1179 - 1185
    04/01/2008 Authors: Landers JE; Leclerc AL; Shi L; Virkud A; Cho T; Maxwell MM; Henry AF; Polak M; Glass JD; Kwiatkowski TJ
  • Freezing of gait in primary lateral sclerosis
    Volume: 23 Page(s): S264 - S264
    01/01/2008 Authors: Aia PG; Glass JD; Factor SA
  • In vivo survivors of transformed mouse ovarian surface epithelial cells display diverse phenotypes for gene expression and tumorigenicity.
    Tumour Biol Volume: 29 Page(s): 359 - 370
    01/01/2008 Authors: Li X-L; Zhang D-Q; Wang D; Knight DS; Yin L; Bao J; Liu Y-Y; Glass J; Mathis JM; Zhang Q-J
  • Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS.
    Neurology Volume: 69 Page(s): 2236 - 2242
    12/11/2007 Authors: Hammad M; Silva A; Glass J; Sladky JT; Benatar M
  • Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery.
    PLoS One Volume: 2 Page(s): e1254
    12/05/2007 Authors: Gwinn K; Corriveau RA; Mitsumoto H; Bednarz K; Brown RH; Cudkowicz M; Gordon PH; Hardy J; Kasarskis EJ; Kaufmann P
  • Radiation-induced tumor after stereotactic radiosurgery for an arteriovenous malformation: case report.
    Neurosurgery Volume: 61 Page(s): E1099
    11/01/2007 Authors: Berman EL; Eade TN; Brown D; Weaver M; Glass J; Zorman G; Feigenberg SJ
  • UPS inhibition and caspase activation in taxol induced distal axonal degeneration
    Volume: 62 Page(s): 544 - 545
    11/01/2007 Authors: Hoke A; Melli G; Glass J; Clifford K
  • Unexpected dementia following prophylactic cranial irradiation for small cell lung cancer: case report.
    J Neurooncol Volume: 85 Page(s): 77 - 79
    10/01/2007 Authors: D'Ambrosio DJ; Cohen RB; Glass J; Konski A; Buyyounouski MK; Feigenberg SJ
  • Mechanisms of axonal degeneration in toxic neuropathies identified by compartmentalized culture system
    Volume: 12 Page(s): 21 - 21
    07/01/2007 Authors: Clifford K; Melli G; Glass JD; Hoke A
  • Selecting promising ALS therapies in clinical trials.
    Neurology Volume: 68 Page(s): 1545 - 1546
    05/01/2007 Authors: Glass JD; Benatar M; Polak M
  • Spatiotemporal localization of injury potentials in DRG neurons during vincristine-induced axonal degeneration.
    Neurosci Lett Volume: 415 Page(s): 34 - 39
    03/19/2007 Authors: Ravula SK; Wang MS; McClain MA; Asress SA; Frazier B; Glass JD
  • Mammalian target of rapamycin inhibitors as possible adjuvant therapy for microscopic residual disease in head and neck squamous cell cancer.
    Cancer Res Volume: 67 Page(s): 2160 - 2168
    03/01/2007 Authors: Nathan C-AO; Amirghahari N; Rong X; Giordano T; Sibley D; Nordberg M; Glass J; Agarwal A; Caldito G
  • A compartmented neuronal culture system in microdevice format.
    J Neurosci Methods Volume: 159 Page(s): 78 - 85
    01/15/2007 Authors: Ravula SK; Wang MS; Asress SA; Glass JD; Bruno Frazier A
  • NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration.
    Cell Death Differ Volume: 14 Page(s): 116 - 127
    01/01/2007 Authors: Conforti L; Fang G; Beirowski B; Wang MS; Sorci L; Asress S; Adalbert R; Silva A; Bridge K; Huang XP
  • Axonal degeneration in motor neuron disease.
    Neurodegener Dis Volume: 4 Page(s): 431 - 442
    01/01/2007 Authors: Fischer LR; Glass JD
  • Preventing familial amyotrophic lateral sclerosis: is a clinical trial feasible?
    J Neurol Sci Volume: 251 Page(s): 3 - 9
    12/21/2006 Authors: Benatar M; Polak M; Kaplan S; Glass J
  • A multielectrode microcompartment culture platform for studying signal transduction in the nervous system.
    Lab Chip Volume: 6 Page(s): 1530 - 1536
    12/01/2006 Authors: Ravula SK; McClain MA; Wang MS; Glass JD; Frazier AB
  • Evidence for direct axonal toxicity in vincristine neuropathy.
    J Peripher Nerv Syst Volume: 11 Page(s): 211 - 216
    09/01/2006 Authors: Silva A; Wang Q; Wang M; Ravula SK; Glass JD
  • Central and peripheral demyelination "a clinical and neurophysiological continuum"
    EUROPEAN JOURNAL OF NEUROLOGY Volume: 13 Page(s): 226 - 226
    09/01/2006 Authors: Licnic VS; Glass JD; Gherman DG; Gavriliuc MI; Crani TS; Plesca SM
  • Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma.
    Epilepsia Volume: 47 Page(s): 1237 - 1238
    07/01/2006 Authors: Ngo L; Nei M; Glass J
  • Treatment of acute myeloid leukemia in a Jehovah's Witness.
    Ann Hematol Volume: 85 Page(s): 407 - 408
    06/01/2006 Authors: Dalal S; Boddapati M; Lowery MN; Veillon DM; Glass J; Munker R
  • Neurologic complications of lymphoma and leukemia.
    Semin Oncol Volume: 33 Page(s): 342 - 347
    06/01/2006 Authors: Glass J
  • Iron Imports. V. Transport of iron through the intestinal epithelium.
    Am J Physiol Gastrointest Liver Physiol Volume: 290 Page(s): G417 - G422
    03/01/2006 Authors: Ma Y; Yeh M; Yeh K-Y; Glass J
  • PET imaging today: contribution to the initial staging and prognosis of patients with non-Hodgkin's lymphomas.
    J La State Med Soc Volume: 158 Page(s): 193 - 201
    01/01/2006 Authors: Sattar T; Griffeth LK; Latifi HR; Glass J; Munker R; Lilien DL
  • Many ways to kill an axon: Multiple mechanisms of axonal degeneration in toxic neuropathies identified by compartmentalized culture system
    Volume: 60 Page(s): S18 - S18
    01/01/2006 Authors: Melli G; Glass JD; Hoke A
  • RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
    J Cell Biochem Volume: 97 Page(s): 1 - 17
    01/01/2006 Authors: Fowler M; Borazanci E; McGhee L; Pylant SW; Williams BJ; Glass J; Davis JN; Meyers S
  • Central nervous system cancers: Clinical Practice Guidelines in Oncology.
    J Natl Compr Canc Netw Volume: 3 Page(s): 644 - 690
    09/01/2005 Authors: Brem SS; Bierman PJ; Black P; Blumenthal DT; Brem H; Chamberlain MC; Chiocca EA; DeAngelis LM; Fenstermaker RA; Fine HA
  • Severe neuropathy with leaky connexin32 hemichannels.
    Ann Neurol Volume: 57 Page(s): 749 - 754
    05/01/2005 Authors: Liang GSL; de Miguel M; Gmez-Hernndez JM; Glass JD; Scherer SS; Mintz M; Barrio LC; Fischbeck KH
  • Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature.
    Am J Hematol Volume: 78 Page(s): 288 - 294
    04/01/2005 Authors: Saccaro S; Fonseca R; Veillon DM; Cotelingam J; Nordberg ML; Bredeson C; Glass J; Munker R
  • The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse.
    Neurobiol Dis Volume: 19 Page(s): 293 - 300
    01/01/2005 Authors: Fischer LR; Culver DG; Davis AA; Tennant P; Wang M; Coleman M; Asress S; Adalbert R; Alexander GM; Glass JD
  • Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease.
    Ann Oncol Volume: 15 Page(s): 1699 - 1704
    11/01/2004 Authors: Munker R; Glass J; Griffeth LK; Sattar T; Zamani R; Heldmann M; Shi R; Lilien DL
  • Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease.
    Neurology Volume: 63 Page(s): 1376 - 1384
    10/26/2004 Authors: Cairns NJ; Grossman M; Arnold SE; Burn DJ; Jaros E; Perry RH; Duyckaerts C; Stankoff B; Pillon B; Skullerud K
  • Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Clin Cancer Res Volume: 10 Page(s): 5820 - 5827
    09/01/2004 Authors: Nathan C-AO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
  • IGF-I and breast cancer: a meta-analysis.
    Int J Cancer Volume: 111 Page(s): 418 - 423
    09/01/2004 Authors: Shi R; Yu H; McLarty J; Glass J
  • Increased intraepidermal CGRP correlates with local immunosuppression after repeated broadband and narrowband UVB
    Volume: 13 Page(s): 585 - 585
    09/01/2004 Authors: Legat FJ; Wolf P; Jaiani LT; Lang R; Wang MS; Armstrong CA; Ansel JC; Glass JD
  • Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer.
    Gynecol Oncol Volume: 94 Page(s): 685 - 692
    09/01/2004 Authors: Katsaros D; Cho W; Singal R; Fracchioli S; Rigault De La Longrais IA; Arisio R; Massobrio M; Smith M; Zheng W; Glass J
  • Mitochondrial abnormalities in dermatomyositis: characteristic pattern of neuropathology.
    J Mol Histol Volume: 35 Page(s): 615 - 619
    08/01/2004 Authors: Alhatou MI; Sladky JT; Bagasra O; Glass JD
  • Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth.
    Clin Cancer Res Volume: 10 Page(s): 5187 - 5201
    08/01/2004 Authors: Landen JW; Hau V; Wang M; Davis T; Ciliax B; Wainer BH; Van Meir EG; Glass JD; Joshi HC; Archer DR
  • Wallerian degeneration as a window to peripheral neuropathy.
    J Neurol Sci Volume: 220 Page(s): 123 - 124
    05/15/2004 Authors: Glass JD
  • The role of calcitonin gene-related peptide in cutaneous immunosuppression induced by repeated subinflammatory ultraviolet irradiation exposure.
    Exp Dermatol Volume: 13 Page(s): 242 - 250
    04/01/2004 Authors: Legat FJ; Jaiani LT; Wolf P; Wang M; Lang R; Abraham T; Solomon AR; Armstrong CA; Glass JD; Ansel JC
  • Calpain inhibition protects against Taxol-induced sensory neuropathy.
    Brain Volume: 127 Page(s): 671 - 679
    03/01/2004 Authors: Wang MS; Davis AA; Culver DG; Wang Q; Powers JC; Glass JD
  • Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat.
    Am J Physiol Gastrointest Liver Physiol Volume: 286 Page(s): G385 - G394
    03/01/2004 Authors: Yeh K-Y; Yeh M; Glass J
  • Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.
    Exp Neurol Volume: 185 Page(s): 232 - 240
    02/01/2004 Authors: Fischer LR; Culver DG; Tennant P; Davis AA; Wang M; Castellano-Sanchez A; Khan J; Polak MA; Glass JD
  • NS 398 radiosensitizes an HNSCC cell line by possibly inhibiting radiation-induced expression of COX-2.
    Int J Radiat Oncol Biol Phys Volume: 57 Page(s): 1405 - 1412
    12/01/2003 Authors: Amirghahari N; Harrison L; Smith M; Rong X; Naumann I; Ampil F; Shi R; Glass J; Nathan CAO
  • ALS is a "dying-back" distal axonopathy: Evidence in mice and man
    Volume: 54 Page(s): 846 - 846
    12/01/2003 Authors: Glass JD; Fischer LR; Culver D; Wang MS; Davis AA; Tennant P; Polak M; Khan J; Castollano AS
  • Controlled intermittent asystole cardiac therapy induced by pharmacologically potentiated vagus nerve stimulation in normal and hibernating myocardium.
    Ann Thorac Surg Volume: 75 Page(s): 1929 - 1936
    06/01/2003 Authors: Ronson RS; Puskas JD; Thourani VH; Velez DA; Bufkin BL; Glass J; Guyton RA; Vinten-Johansen J
  • Stable inheritance of an 85-kb triplication in C57BL/WldS mice.
    Mutat Res Volume: 526 Page(s): 33 - 37
    05/15/2003 Authors: Mi W; Glass JD; Coleman MP
  • Unusual neuropathologic findings in a case of primary lateral sclerosis.
    Volume: 62 Page(s): 555 - 555
    05/01/2003 Authors: Gearing M; Castellano AA; Hunter SB; Brat DJ; Glass JD; Santoianni R; Juncos JL
  • Poliomyelitis due to West Nile virus.
    N Engl J Med Volume: 347 Page(s): 1280 - 1281
    10/17/2002 Authors: Glass JD; Samuels O; Rich MM
  • WldS mice are resistant to paclitaxel (taxol) neuropathy.
    Ann Neurol Volume: 52 Page(s): 442 - 447
    10/01/2002 Authors: Wang MS; Davis AA; Culver DG; Glass JD
  • The transcytosis of divalent metal transporter 1 and apo-transferrin during iron uptake in intestinal epithelium.
    Am J Physiol Gastrointest Liver Physiol Volume: 283 Page(s): G965 - G974
    10/01/2002 Authors: Ma Y; Specian RD; Yeh K-Y; Yeh M; Rodriguez-Paris J; Glass J
  • A practical approach to the diagnosis and management of MELAS: case report and review.
    Neurologist Volume: 8 Page(s): 302 - 312
    09/01/2002 Authors: Thambisetty M; Newman NJ; Glass JD; Frankel MR
  • Very early activation of m-calpain in peripheral nerve during Wallerian degeneration.
    J Neurol Sci Volume: 196 Page(s): 9 - 20
    04/15/2002 Authors: Glass JD; Culver DG; Levey AI; Nash NR
  • Trinucleotide repeat counts and self-reported daytime sleepiness in myotonic dystrophy
    SLEEP Volume: 25 Page(s): A257 - A258
    04/15/2002 Authors: Syed BH; Glass JD; Bliwise DL; Rye DB
  • The WldS protein protects against axonal degeneration: a model of gene therapy for peripheral neuropathy.
    Ann Neurol Volume: 50 Page(s): 773 - 779
    12/01/2001 Authors: Wang MS; Fang G; Culver DG; Davis AA; Rich MM; Glass JD
  • Prolymphocytic leukemia or prolymphocytic transformation of mantle cell lymphoma.
    Am J Clin Pathol Volume: 116 Page(s): 781 - 782
    11/01/2001 Authors: Veillon DM; Nordberg ML; Glass J; Sattar T; Cotelingam JD
  • COX-2 expression in dysplasia of the head and neck: correlation with elF4E.
    Cancer Volume: 92 Page(s): 1888 - 1895
    10/01/2001 Authors: Nathan CA; Leskov IL; Lin M; Abreo FW; Shi R; Hartman GH; Glass J
  • Increased frequency of the tumor necrosis factor-alpha-308 A allele in adults with human immunodeficiency virus dementia.
    Ann Neurol Volume: 50 Page(s): 157 - 162
    08/01/2001 Authors: Quasney MW; Zhang Q; Sargent S; Mynatt M; Glass J; McArthur J
  • Breast cancer: a socioeconomic and racial comparison in northwest Louisiana.
    J La State Med Soc Volume: 153 Page(s): 420 - 425
    08/01/2001 Authors: Li A; Burton G; Glass J
  • Microglia in HIV-associated neurological diseases.
    Microsc Res Tech Volume: 54 Page(s): 95 - 105
    07/15/2001 Authors: Glass JD; Wesselingh SL
  • Genetic deletions of NCAM and PSA impair circadian function in the mouse.
    Physiol Behav Volume: 73 Page(s): 185 - 193
    05/01/2001 Authors: Shen H; Watanabe M; Tomasiewicz H; Glass JD
  • The gene for slow Wallerian degeneration (Wld(s)) is also protective against vincristine neuropathy.
    Neurobiol Dis Volume: 8 Page(s): 155 - 161
    02/01/2001 Authors: Wang M; Wu Y; Culver DG; Glass JD
  • Dietary iron induces rapid changes in rat intestinal divalent metal transporter expression.
    Am J Physiol Gastrointest Liver Physiol Volume: 279 Page(s): G1070 - G1079
    11/01/2000 Authors: Yeh KY; Yeh M; Watkins JA; Rodriguez-Paris J; Glass J
  • Zinc transport and metallothionein secretion in the intestinal human cell line Caco-2.
    J Biol Chem Volume: 275 Page(s): 31819 - 31825
    10/13/2000 Authors: Moltedo O; Verde C; Capasso A; Parisi E; Remondelli P; Bonatti S; Alvarez-Hernandez X; Glass J; Alvino CG; Leone A
  • Pathogenesis of axonal degeneration: parallels between Wallerian degeneration and vincristine neuropathy.
    J Neuropathol Exp Neurol Volume: 59 Page(s): 599 - 606
    07/01/2000 Authors: Wang MS; Wu Y; Culver DG; Glass JD
  • Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications.
    Cancer Res Volume: 60 Page(s): 3599 - 3604
    07/01/2000 Authors: Nathan CA; Sanders K; Abreo FW; Nassar R; Glass J
  • Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin.
    AJNR Am J Neuroradiol Volume: 21 Page(s): 881 - 890
    05/01/2000 Authors: Cha S; Knopp EA; Johnson G; Litt A; Glass J; Gruber ML; Lu S; Zagzag D
  • Rapid activation of NF-kappaB and AP-1 and target gene expression in postischemic rat intestine.
    Gastroenterology Volume: 118 Page(s): 525 - 534
    03/01/2000 Authors: Yeh KY; Yeh M; Glass J; Granger DN
  • Polysialylated neural cell adhesion molecule modulates photic signaling in the mouse suprachiasmatic nucleus.
    Neurosci Lett Volume: 280 Page(s): 207 - 210
    02/25/2000 Authors: Glass JD; Shen H; Fedorkova L; Chen L; Tomasiewicz H; Watanabe M
  • Glucocorticoids and dietary iron regulate postnatal intestinal heavy and light ferritin expression in rats.
    Am J Physiol Gastrointest Liver Physiol Volume: 278 Page(s): G217 - G226
    02/01/2000 Authors: Yeh KY; Yeh M; Glass J
  • Evidence for the induction of apoptosis by endosulfan in a human T-cell leukemic line.
    Mol Cell Biochem Volume: 205 Page(s): 53 - 66
    02/01/2000 Authors: Kannan K; Holcombe RF; Jain SK; Alvarez-Hernandez X; Chervenak R; Wolf RE; Glass J
  • Apo-transferrin is internalized and routed differently from Fe-transferrin by caco-2 cells: a confocal microscopy study of vesicular transport in intestinal cells.
    Blood Volume: 95 Page(s): 721 - 723
    01/15/2000 Authors: Alvarez-Hernandez X; Smith M; Glass J
  • Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance.
    Epidemiol Rev Volume: 22 Page(s): 298 - 316
    01/01/2000 Authors: Marx A; Glass JD; Sutter RW
  • Localization of HIV-1 DNA and tumor necrosis factor-alpha mRNA in human brain using polymerase chain reaction in situ hybridization and immunocytochemistry.
    Methods Mol Biol Volume: 123 Page(s): 323 - 337
    01/01/2000 Authors: Wesselingh SL; Glass JD
  • A Unique Mutation in Connexin32 Associated with Severe, Early Onset CMTX in a Heterozygous Female.
    Ann N Y Acad Sci Volume: 883 Page(s): 481 - 484
    10/01/1999 Authors: Lin GS; Glass JD; Shumas S; Scherer SS; Fischbeck KH
  • A unique mutation in connexin32 associated with severe, early onset CMTX in a heterozygous female.
    Ann N Y Acad Sci Volume: 883 Page(s): 481 - 484
    09/14/1999 Authors: Lin GS; Glass JD; Shumas S; Scherer SS; Fischbeck KH
  • Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer.
    J Clin Oncol Volume: 17 Page(s): 2909 - 2914
    09/01/1999 Authors: Nathan CO; Franklin S; Abreo FW; Nassar R; De Benedetti A; Glass J
  • Generation of spectrin breakdown products in peripheral nerves by addition of M-calpain.
    Muscle Nerve Volume: 22 Page(s): 905 - 909
    07/01/1999 Authors: Castejon MS; Culver DG; Glass JD
  • Axonal neurofilaments are resistant to calpain-mediated degradation in the WLD(S) mouse.
    Neuroreport Volume: 10 Page(s): 1423 - 1426
    05/14/1999 Authors: Bernier B; Castejon S; Culver DG; Glass JD
  • Expression of intestinal brush-border membrane hydrolases and ferritin after segmental ischemia-reperfusion in rats.
    Am J Physiol Volume: 275 Page(s): G572 - G583
    09/01/1998 Authors: Yeh KY; Yeh M; Glass J
  • Rapid changes in m-calpain after axotomy but before wallerian degeneration
    ANNALS OF NEUROLOGY Volume: 44 Page(s): 462 - 462
    09/01/1998 Authors: Glass JD; Culver DG; Levey AI; Nash N
  • Brain-derived HIV-1 tat sequences from AIDS patients with dementia show increased molecular heterogeneity.
    J Neurovirol Volume: 4 Page(s): 387 - 393
    08/01/1998 Authors: Bratanich AC; Liu C; McArthur JC; Fudyk T; Glass JD; Mittoo S; Klassen GA; Power C
  • Carboplatin chemotherapy before irradiation in newly diagnosed glioblastoma multiforme.
    Am J Clin Oncol Volume: 21 Page(s): 338 - 340
    08/01/1998 Authors: Gruber ML; Glass J; Choudhri H; Nirenberg A
  • Viral load in HIV-associated dementia.
    Ann Neurol Volume: 44 Page(s): 150 - 151
    07/01/1998 Authors: Glass JD; Wesselingh SL
  • Calpain-mediated spectrin-breakdown products in peripheral nerve: A marker of axonal degeneration
    BRAIN PATHOLOGY Volume: 8 Page(s): 581 - 581
    07/01/1998 Authors: Casteljon MS; Culver D; Glass JD
  • Cloning of m-calpain 80 kD subunit from the axonal degeneration-resistant WLD(S) mouse mutant.
    J Neurosci Res Volume: 52 Page(s): 653 - 660
    06/15/1998 Authors: Glass JD; Nash N; Dry I; Culver D; Levey AI; Wesselingh S
  • Variable progression of HIV-associated dementia.
    Neurology Volume: 50 Page(s): 1814 - 1820
    06/01/1998 Authors: Bouwman FH; Skolasky RL; Hes D; Selnes OA; Glass JD; Nance-Sproson TE; Royal W; Dal Pan GJ; McArthur JC
  • The effect of apotransferrin on iron release from Caco-2 cells, an intestinal epithelial cell line.
    Blood Volume: 91 Page(s): 3974 - 3979
    05/15/1998 Authors: Alvarez-Hernandez X; Smith M; Glass J
  • A new gatekeeper for back pain.
    Am J Manag Care Volume: 4 Page(s): 576 - 579
    04/01/1998 Authors: Horwitz AD; Hosek R; Boyle J; Cianciulli A; Glass J; Codario R
  • HIV-associated brain pathology: a comparative international study.
    Neuropathol Appl Neurobiol Volume: 24 Page(s): 118 - 124
    04/01/1998 Authors: Davies J; Everall IP; Weich S; Glass J; Sharer LR; Cho ES; Bell JE; Majteny C; Gray F; Scaravilli F
  • Magnetic resonance imaging features of solitary inflammatory brain masses.
    J Neuroimaging Volume: 8 Page(s): 8 - 14
    01/01/1998 Authors: Bakshi R; Glass J; Louis DN; Hochberg FH
  • Transforming growth factor-beta1 in adult human microglia and its stimulated production by interleukin-1.
    J Interferon Cytokine Res Volume: 17 Page(s): 655 - 664
    11/01/1997 Authors: da Cunha A; Jefferson JJ; Tyor WR; Glass JD; Jannotta FS; Cottrell JR; Resau JH
  • Calpains and calpastatin in axonal degeneration
    ANNALS OF NEUROLOGY Volume: 42 Page(s): M102 - M102
    09/01/1997 Authors: Glass JD; GoodwinCulver D; Castejon S; Nash N; Levey AI; Powers J
  • Role of neural cell adhesion molecule and polysialic acid in mouse circadian clock function.
    J Neurosci Volume: 17 Page(s): 5221 - 5229
    07/01/1997 Authors: Shen H; Watanabe M; Tomasiewicz H; Rutishauser U; Magnuson T; Glass JD
  • Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma.
    Am J Clin Oncol Volume: 20 Page(s): 226 - 229
    06/01/1997 Authors: Glass J; Silverman CL; Axelrod R; Corn BW; Andrews DW
  • Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry.
    J Neuroimmunol Volume: 74 Page(s): 1 - 8
    04/01/1997 Authors: Wesselingh SL; Takahashi K; Glass JD; McArthur JC; Griffin JW; Griffin DE
  • Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41.
    Science Volume: 274 Page(s): 1917 - 1921
    12/13/1996 Authors: Adamson DC; Wildemann B; Sasaki M; Glass JD; McArthur JC; Christov VI; Dawson TM; Dawson VL
  • Therapy of primary central nervous system lymphoma with pre-irradiation methotrexate, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (MCHOD).
    J Neurooncol Volume: 30 Page(s): 257 - 265
    12/01/1996 Authors: Glass J; Shustik C; Hochberg FH; Cher L; Gruber ML
  • Knowledge and attitude on screening mammography among low-literate, low-income women.
    Cancer Volume: 78 Page(s): 1912 - 1920
    11/01/1996 Authors: Davis TC; Arnold C; Berkel HJ; Nandy I; Jackson RH; Glass J
  • Stereological analysis of cerebral atrophy in human immunodeficiency virus-associated dementia.
    J Neuropathol Exp Neurol Volume: 55 Page(s): 1032 - 1037
    10/01/1996 Authors: Subbiah P; Mouton P; Fedor H; McArthur JC; Glass JD
  • Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry.
    Ann Neurol Volume: 39 Page(s): 705 - 711
    06/01/1996 Authors: Takahashi K; Wesselingh SL; Griffin DE; McArthur JC; Johnson RT; Glass JD
  • Human immunodeficiency virus in brain and correlation with dementia - Reply
    ANNALS OF NEUROLOGY Volume: 39 Page(s): 829 - 829
    06/01/1996 Authors: Glass JD; McArthur JC
  • Human immunodeficiency virus in brain and correlation with dementia.
    Ann Neurol Volume: 39 Page(s): 828 - 829
    06/01/1996 Authors: Brew BJ
  • Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results.
    Neurology Volume: 46 Page(s): 1757 - 1759
    06/01/1996 Authors: Cher L; Glass J; Harsh GR; Hochberg FH
  • Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome.
    Ann Neurol Volume: 39 Page(s): 392 - 395
    03/01/1996 Authors: Johnson RT; Glass JD; McArthur JC; Chesebro BW
  • Rat intestinal and hepatic ferritin subunit expression during development and after dietary iron feeding.
    Am J Physiol Volume: 270 Page(s): G498 - G505
    03/01/1996 Authors: Yeh KY; Alvarez-Hernandez X; Glass J; Yeh M
  • Human immunodeficiency virus and the brain.
    Annu Rev Neurosci Volume: 19 Page(s): 1 - 26
    01/01/1996 Authors: Glass JD; Johnson RT
  • Neuronal pattern correlates with the severity of human immunodeficiency virus-associated dementia complex. Usefulness of spatial pattern analysis in clinicopathological studies.
    Am J Pathol Volume: 148 Page(s): 31 - 38
    01/01/1996 Authors: Asare E; Dunn G; Glass J; McArthur J; Luthert P; Lantos P; Everall I
  • A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia.
    Brain Behav Immun Volume: 9 Page(s): 366 - 377
    12/01/1995 Authors: Rho MB; Wesselingh S; Glass JD; McArthur JC; Choi S; Griffin J; Tyor WR
  • Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia.
    Ann Neurol Volume: 38 Page(s): 755 - 762
    11/01/1995 Authors: Glass JD; Fedor H; Wesselingh SL; McArthur JC
  • Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels.
    J Neurosci Volume: 15 Page(s): 6445 - 6452
    10/01/1995 Authors: George EB; Glass JD; Griffin JW
  • Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility.
    Acta Radiol Volume: 36 Page(s): 520 - 528
    09/01/1995 Authors: Aronen HJ; Glass J; Pardo FS; Belliveau JW; Gruber ML; Buchbinder BR; Gazit IE; Linggood RM; Fischman AJ; Rosen BR
  • Prolonged axonal survival in transected nerves of C57BL/Ola mice is independent of age.
    J Neurocytol Volume: 24 Page(s): 333 - 340
    05/01/1995 Authors: Crawford TO; Hsieh ST; Schryer BL; Glass JD
  • Iron binding, a new function for the reticulocyte endosome H(+)-ATPase.
    Biochemistry Volume: 34 Page(s): 5130 - 5136
    04/18/1995 Authors: Li CY; Watkins JA; Hamazaki S; Altazan JD; Glass J
  • Nerve conduction studies in diabetic neuropathy.
    Neurology Volume: 45 Page(s): 849 - 850
    04/01/1995 Authors: Walker FO
  • Autosomal dominant distal spinal muscular atrophy in four generations.
    Neurology Volume: 45 Page(s): 699 - 704
    04/01/1995 Authors: Boylan KB; Cornblath DR; Glass JD; Alderson K; Kuncl RW; Kleyn PW; Gilliam TC
  • Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence.
    Curr Top Microbiol Immunol Volume: 202 Page(s): 89 - 104
    01/01/1995 Authors: Power C; McArthur JC; Johnson RT; Griffin DE; Glass JD; Dewey R; Chesebro B
  • Role of redox systems on Fe3+ uptake by transformed human intestinal epithelial (Caco-2) cells.
    Am J Physiol Volume: 267 Page(s): C1582 - C1588
    12/01/1994 Authors: Nez MT; Alvarez X; Smith M; Tapia V; Glass J
  • HIV dementia.
    Neurology Volume: 44 Page(s): 2214
    11/01/1994 Authors: Brew BJ
  • Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsy-based case-control study.
    Neurology Volume: 44 Page(s): 2159 - 2164
    11/01/1994 Authors: Dal Pan GJ; Glass JD; McArthur JC
  • Chronic inflammatory demyelinating polyneuropathy and paraproteinemic neuropathies.
    Curr Opin Neurol Volume: 7 Page(s): 393 - 397
    10/01/1994 Authors: Glass JD; Cornblath DR
  • Iron status affects aluminum uptake and transport by Caco-2 cells.
    J Nutr Volume: 124 Page(s): 1574 - 1580
    09/01/1994 Authors: Alvarez-Hernandez X; Madigosky SR; Stewart B; Glass J
  • Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome.
    J Neurosurg Volume: 81 Page(s): 188 - 195
    08/01/1994 Authors: Glass J; Gruber ML; Cher L; Hochberg FH
  • Inter- and intraexaminer reliability of nerve conduction measurements in patients with diabetic neuropathy.
    Neurology Volume: 44 Page(s): 1459 - 1462
    08/01/1994 Authors: Chaudhry V; Corse AM; Freimer ML; Glass JD; Mellits ED; Kuncl RW; Quaskey SA; Cornblath DR
  • Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences.
    J Virol Volume: 68 Page(s): 4643 - 4649
    07/01/1994 Authors: Power C; McArthur JC; Johnson RT; Griffin DE; Glass JD; Perryman S; Chesebro B
  • Regulation of iron uptake and transport by transferrin in Caco-2 cells, an intestinal cell line.
    Biochim Biophys Acta Volume: 1192 Page(s): 215 - 222
    06/22/1994 Authors: Alvarez-Hernandez X; Smith M; Glass J
  • Retrograde transport of radiolabeled cytoskeletal proteins in transected nerves.
    J Neurosci Volume: 14 Page(s): 3915 - 3921
    06/01/1994 Authors: Glass JD; Griffin JW
  • Calcium-mediated degeneration of the axonal cytoskeleton in the Ola mouse.
    J Neurochem Volume: 62 Page(s): 2472 - 2475
    06/01/1994 Authors: Glass JD; Schryer BL; Griffin JW
  • Baseline silent cerebral infarction in the Asymptomatic Carotid Atherosclerosis Study.
    Stroke Volume: 25 Page(s): 1122 - 1129
    06/01/1994 Authors: Brott T; Tomsick T; Feinberg W; Johnson C; Biller J; Broderick J; Kelly M; Frey J; Schwartz S; Blum C
  • The H(+)-ATPase from reticulocyte endosomes reconstituted into liposomes acts as an iron transporter.
    J Biol Chem Volume: 269 Page(s): 10242 - 10246
    04/08/1994 Authors: Li CY; Watkins JA; Glass J
  • Aluminum alters the compartmentalization of iron in Friend erythroleukemia cells.
    Kidney Int Volume: 45 Page(s): 636 - 641
    03/01/1994 Authors: Abreo K; Glass J; Jain S; Sella M
  • Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS).
    Neurology Volume: 44 Page(s): 507 - 514
    03/01/1994 Authors: Holland NR; Power C; Mathews VP; Glass JD; Forman M; McArthur JC
  • HIV dementia. Incidence and risk factors.
    Res Publ Assoc Res Nerv Ment Dis Volume: 72 Page(s): 251 - 272
    01/01/1994 Authors: McArthur JC; Selnes OA; Glass JD; Hoover DR; Bacellar H
  • Peripheral nerve disorders in HIV infection. Similarities and contrasts with CNS disorders.
    Res Publ Assoc Res Nerv Ment Dis Volume: 72 Page(s): 159 - 182
    01/01/1994 Authors: Griffin JW; Wesselingh SL; Griffin DE; Glass JD; McArthur JC
  • Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia.
    Acta Neuropathol Volume: 88 Page(s): 538 - 544
    01/01/1994 Authors: Everall IP; Glass JD; McArthur J; Spargo E; Lantos P
  • Cytokine dysregulation in HIV-associated neurological disease.
    Volume: 4 Page(s): 199 - 206
    01/01/1994 Authors: Wesselingh SL; Glass J; McArthur JC; Griffin JW; Griffin DE
  • Control of astrocytosis by interleukin-1 and transforming growth factor-beta 1 in human brain.
    Brain Res Volume: 631 Page(s): 39 - 45
    12/17/1993 Authors: da Cunha A; Jefferson JJ; Tyor WR; Glass JD; Jannotta FS; Vitkovi L
  • Clinical-neuropathologic correlation in HIV-associated dementia.
    Neurology Volume: 43 Page(s): 2230 - 2237
    11/01/1993 Authors: Glass JD; Wesselingh SL; Selnes OA; McArthur JC
  • Redistribution of cytoskeletal proteins in mammalian axons disconnected from their cell bodies.
    J Neurosci Volume: 13 Page(s): 4354 - 4360
    10/01/1993 Authors: Watson DF; Glass JD; Griffin JW
  • Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier.
    Ann Neurol Volume: 34 Page(s): 339 - 350
    09/01/1993 Authors: Power C; Kong PA; Crawford TO; Wesselingh S; Glass JD; McArthur JC; Trapp BD
  • Rapid diagnosis of cytomegalovirus polyradiculitis in a patient with acquired immunodeficiency syndrome.
    Ann Neurol Volume: 34 Page(s): 239
    08/01/1993 Authors: Glass JD; Erozan YS
  • Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia.
    Ann Neurol Volume: 33 Page(s): 576 - 582
    06/01/1993 Authors: Wesselingh SL; Power C; Glass JD; Tyor WR; McArthur JC; Farber JM; Griffin JW; Griffin DE
  • Intravascular lymphomatosis. A systemic disease with neurologic manifestations.
    Cancer Volume: 71 Page(s): 3156 - 3164
    05/15/1993 Authors: Glass J; Hochberg FH; Miller DC
  • Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axon.
    J Neurocytol Volume: 22 Page(s): 311 - 321
    05/01/1993 Authors: Glass JD; Brushart TM; George EB; Griffin JW
  • Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy.
    Neurology Volume: 43 Page(s): 1002 - 1009
    05/01/1993 Authors: Tyor WR; Glass JD; Baumrind N; McArthur JC; Griffin JW; Becker PS; Griffin DE
  • CYTOKINE MESSENGER-RNA EXPRESSION IN HIV ASSOCIATED NEUROLOGICAL DISEASE
    JOURNAL OF CELLULAR BIOCHEMISTRY Page(s): 78 - 78
    03/13/1993 Authors: WESSELINGH SL; POWER C; FOX R; CHOI S; MCARTHUR J; GLASS J; GRIFFIN J; GRIFFIN D
  • Neurologic prognosis of cytomegalovirus polyradiculomyelopathy in AIDS.
    Neurology Volume: 43 Page(s): 493 - 499
    03/01/1993 Authors: Cohen BA; McArthur JC; Grohman S; Patterson B; Glass JD
  • Gliosis in human brain: relationship to size but not other properties of astrocytes.
    Brain Res Volume: 600 Page(s): 161 - 165
    01/08/1993 Authors: da Cunha A; Jefferson JJ; Tyor WR; Glass JD; Jannotta FS; Vitkovic L
  • Cellular, biochemical, and molecular mechanisms of aluminium toxicity.
    Volume: 8 Suppl 1 Page(s): 5 - 11
    01/01/1993 Authors: Abreo K; Glass J
  • Macrophage responses and myelin clearance during Wallerian degeneration: relevance to immune-mediated demyelination.
    J Neuroimmunol Volume: 40 Page(s): 153 - 165
    10/01/1992 Authors: Griffin JW; George R; Lobato C; Tyor WR; Yan LC; Glass JD
  • Concentrations of aluminum in gut tissue of crayfish (Procambarus clarkii), purged in sodium chloride.
    Bull Environ Contam Toxicol Volume: 49 Page(s): 626 - 632
    10/01/1992 Authors: Madigosky SR; Alvarez-Hernandez X; Glass J
  • Wallerian degeneration in peripheral nerve disease.
    Neurol Clin Volume: 10 Page(s): 613 - 627
    08/01/1992 Authors: Chaudhry V; Glass JD; Griffin JW
  • Kinetic characterization of reductant dependent processes of iron mobilization from endocytic vesicles.
    Biochemistry Volume: 31 Page(s): 5820 - 5830
    06/30/1992 Authors: Watkins JA; Altazan JD; Elder P; Li CY; Nunez MT; Cui XX; Glass J
  • Association of Epstein-Barr virus with primary central nervous system lymphoma in AIDS.
    AIDS Res Hum Retroviruses Volume: 8 Page(s): 740 - 742
    05/01/1992 Authors: MacMahon EM; Glass JD; Hayward SD; Mann RB; Charache P; McArthur JC; Ambinder RF
  • Chronic demyelinating polyneuropathy associated with eosinophilia-myalgia syndrome.
    J Neurol Neurosurg Psychiatry Volume: 55 Page(s): 352 - 358
    05/01/1992 Authors: Freimer ML; Glass JD; Chaudhry V; Tyor WR; Cornblath DR; Griffin JW; Kuncl RW
  • CHANGES IN SUBCORTICAL WHITE MATTER ASSOCIATED WITH HIV-INFECTION
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Volume: 51 Page(s): 355 - 355
    05/01/1992 Authors: POWER C; KONG PA; MCARTHUR JC; GLASS JD; TRAPP BD
  • The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy.
    J Neurosurg Volume: 76 Page(s): 741 - 745
    05/01/1992 Authors: Glass J; Hochberg FH; Gruber ML; Louis DN; Smith D; Rattner B
  • Non-transferrin dependent 59Fe uptake in phytohemagglutinin-stimulated human peripheral lymphocytes.
    Exp Hematol Volume: 20 Page(s): 436 - 441
    05/01/1992 Authors: Hamazaki S; Glass J
  • INTRACEREBRAL CYTOKINE EXPRESSION IN HIV-INFECTION - CLINICOPATHOLOGICAL CORRELATIONS
    CLINICAL RESEARCH Volume: 40 Page(s): A138 - A138
    04/01/1992 Authors: WESSELINGH SL; POWER C; GLASS J; MCARTHUR J; GRIFFIN DE
  • The mechanisms of nonheme iron uptake determined in IEC-6 rat intestinal cells.
    Volume: 122 Page(s): 945 - 952
    04/01/1992 Authors: Nichols GM; Pearce AR; Alverez X; Bibb NK; Nichols KY; Alfred CB; Glass J
  • Cytokine expression in the brain during the acquired immunodeficiency syndrome.
    Ann Neurol Volume: 31 Page(s): 349 - 360
    04/01/1992 Authors: Tyor WR; Glass JD; Griffin JW; Becker PS; McArthur JC; Bezman L; Griffin DE
  • AIDS-related CNS cryptococcosis: radiologic-pathologic correlation.
    AJNR Am J Neuroradiol Volume: 13 Page(s): 1477 - 1486
    01/01/1992 Authors: Mathews VP; Alo PL; Glass JD; Kumar AJ; McArthur JC
  • Inter- and intra-examiner reliability of nerve conduction measurements in normal subjects.
    Ann Neurol Volume: 30 Page(s): 841 - 843
    12/01/1991 Authors: Chaudhry V; Cornblath DR; Mellits ED; Avila O; Freimer ML; Glass JD; Reim J; Ronnett GV; Quaskey SA; Kuncl RW
  • Caco-2 cell line: a system for studying intestinal iron transport across epithelial cell monolayers.
    Biochim Biophys Acta Volume: 1070 Page(s): 205 - 208
    11/18/1991 Authors: Alvarez-Hernandez X; Nichols GM; Glass J
  • Epstein-Barr virus in AIDS-related primary central nervous system lymphoma.
    Lancet Volume: 338 Page(s): 969 - 973
    10/19/1991 Authors: MacMahon EM; Glass JD; Hayward SD; Mann RB; Becker PS; Charache P; McArthur JC; Ambinder RF
  • Neurofilament redistribution in transected nerves: evidence for bidirectional transport of neurofilaments.
    J Neurosci Volume: 11 Page(s): 3146 - 3154
    10/01/1991 Authors: Glass JD; Griffin JW
  • Conduction block in diabetic neuropathy.
    Muscle Nerve Volume: 14 Page(s): 858 - 862
    09/01/1991 Authors: Abu-Shakra SR; Cornblath DR; Avila OL; Chaudhry V; Freimer M; Glass JD; Reim JW; Ronnett GV
  • Aluminum uptake and toxicity in cultured mouse hepatocytes.
    J Am Soc Nephrol Volume: 1 Page(s): 1299 - 1304
    06/01/1991 Authors: Abreo K; Jangula J; Jain SK; Sella M; Glass J
  • THE RESIDENT MACROPHAGE SYSTEM OF PERIPHERAL-NERVES
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Volume: 50 Page(s): 321 - 321
    05/01/1991 Authors: GRIFFIN JW; LOBATO C; GLASS JD
  • MICROGLIA AND MACROPHAGES IN HIV-ASSOCIATED VACUOLAR MYELOPATHY
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Volume: 50 Page(s): 343 - 343
    05/01/1991 Authors: BAUMRIND NL; BECKER PS; GLASS JD; GRIFFIN JW; TRAPP BD
  • Cl-, Na+, and H+ fluxes during the acidification of rabbit reticulocyte endocytic vesicles.
    J Bioenerg Biomembr Volume: 23 Page(s): 147 - 160
    02/01/1991 Authors: Gaete V; Nez MT; Glass J
  • Lead, cadmium, and aluminum accumulation in the red swamp crayfish Procambarus clarkii G. collected from roadside drainage ditches in Louisiana.
    Arch Environ Contam Toxicol Volume: 20 Page(s): 253 - 258
    02/01/1991 Authors: Madigosky SR; Alvarez-Hernandez X; Glass J
  • Kinetics of iron passage through subcellular compartments of rabbit reticulocytes.
    J Membr Biol Volume: 119 Page(s): 141 - 149
    01/01/1991 Authors: Watkins JA; Nunez MT; Gaete V; Alvarez O; Glass J
  • CONDUCTION BLOCK IN DIABETIC NEUROPATHY
    MUSCLE & NERVE Volume: 13 Page(s): 866 - 866
    09/01/1990 Authors: ABUSHAKRA SR; CORNBLATH DR; AVILA O; CHAUDHRY V; FREIMER M; GLASS J; REIM J; RONNETT G
  • Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1.
    J Biol Chem Volume: 265 Page(s): 14572 - 14578
    08/25/1990 Authors: Rogers JT; Bridges KR; Durmowicz GP; Glass J; Auron PE; Munro HN
  • Wilson's disease. Development of neurological disease after beginning penicillamine therapy.
    Arch Neurol Volume: 47 Page(s): 595 - 596
    05/01/1990 Authors: Glass JD; Reich SG; DeLong MR
  • CENTRAL SPINAL MYELINOLYSIS IN AIDS
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Volume: 49 Page(s): 324 - 324
    05/01/1990 Authors: GLASS JD; BECKER PS; PRICE DL
  • INTRAVASCULAR MALIGNANT LYMPHOMATOSIS - A CLINICOPATHOLOGICAL STUDY
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Volume: 49 Page(s): 341 - 341
    05/01/1990 Authors: PARDO CA; GLASS JD; RUGGIO D; MANN RB; RAYMOND LA; TRONCOSO JC
  • The dysarthria-clumsy hand syndrome: a distinct clinical entity related to pontine infarction.
    Ann Neurol Volume: 27 Page(s): 487 - 494
    05/01/1990 Authors: Glass JD; Levey AI; Rothstein JD
  • Mobilization of iron from endocytic vesicles. The effects of acidification and reduction.
    J Biol Chem Volume: 265 Page(s): 6688 - 6692
    04/25/1990 Authors: Nez MT; Gaete V; Watkins JA; Glass J
  • Aluminum inhibits hemoglobin synthesis but enhances iron uptake in Friend erythroleukemia cells.
    Kidney Int Volume: 37 Page(s): 677 - 681
    02/01/1990 Authors: Abreo K; Glass J; Sella M
  • Dural scrofula.
    Neurology Volume: 39 Page(s): 1123 - 1124
    08/01/1989 Authors: Glass JD; Becker PS; Moses H; Troncoso JC
  • Assay and characteristics of the iron binding moiety of reticulocyte endocytic vesicles.
    J Membr Biol Volume: 107 Page(s): 129 - 135
    02/01/1989 Authors: Nunez MT; Pinto I; Glass J
  • Rabbit reticulocyte coated vesicles carrying the transferrin-transferrin receptor complex: I. Purification and partial characterization.
    Blood Volume: 70 Page(s): 1035 - 1039
    10/01/1987 Authors: Choe HR; Moseley ST; Glass J; Nunez MT
  • Microtopography of growth of normal and leukemic murine cells in diffusion-chamber cultures.
    Exp Hematol Volume: 14 Page(s): 719 - 723
    09/01/1986 Authors: Page PL; Pennell SC; Kasdon E; Glass J; Robinson SH
  • Amines as inhibitors of iron transport in rabbit reticulocytes.
    J Biol Chem Volume: 261 Page(s): 8298 - 8302
    06/25/1986 Authors: Glass J; Nunez MT
  • Iron uptake in reticulocytes. Inhibition mediated by the ionophores monensin and nigerisin.
    J Biol Chem Volume: 260 Page(s): 14707 - 14711
    11/25/1985 Authors: Nuez MT; Glass J
  • Mechanisms of iron uptake in reticulocytes.
    Prog Clin Biol Res Volume: 184 Page(s): 369 - 382
    01/01/1985 Authors: Glass J; Nunez MT
  • Iatrogenic cardiac herniation: post mortem case.
    J Trauma Volume: 24 Page(s): 632 - 633
    07/01/1984 Authors: Glass JD; McQuillen EN; Hardin NJ
  • Beta globin messenger RNA content of bone marrow erythroblasts in heterozygous beta-thalassemia.
    Am J Hematol Volume: 16 Page(s): 33 - 45
    01/01/1984 Authors: Benz EJ; Pritchard J; Hillman D; Glass J; Forget BG
  • The transferrin cycle and iron uptake in rabbit reticulocytes. Pulse studies using 59Fe, 125I-labeled transferrin.
    J Biol Chem Volume: 258 Page(s): 9676 - 9680
    08/25/1983 Authors: Nuez MT; Glass J
  • Transferrin binding and iron uptake in mouse hepatocytes.
    Biochim Biophys Acta Volume: 762 Page(s): 102 - 110
    02/16/1983 Authors: Cole ES; Glass J
  • The reticulocyte plasma membrane pathway of iron uptake as determined by the mechanism of alpha, alpha'-dipyridyl inhibition.
    J Biol Chem Volume: 258 Page(s): 1146 - 1151
    01/25/1983 Authors: Nunez MT; Cole ES; Glass J
  • Reconstitution of the transferrin receptor in lipid vesicles. Effect of cholesterol on the binding of transferrin.
    Biochemistry Volume: 21 Page(s): 4139 - 4143
    08/17/1982 Authors: Nunez MT; Glass J
  • Radiotherapy as a cause of complete atrioventricular block in Hodgkin's disease. An electrophysiological-pathological correlation.
    Arch Intern Med Volume: 141 Page(s): 676 - 679
    04/01/1981 Authors: Cohen SI; Bharati S; Glass J; Lev M
  • the stability in various detergents of transferrin-transferrin receptor complexes from reticulocyte plasma membranes.
    Biochim Biophys Acta Volume: 673 Page(s): 137 - 146
    02/18/1981 Authors: Nunez MT; Glass J; Cole ES
  • Cytosol intermediates in the transport of iron.
    Blood Volume: 55 Page(s): 1051 - 1055
    06/01/1980 Authors: Nunez MT; Cole ES; Glass J
  • Transferrin-binding and iron-binding proteins of rabbit reticulocyte plasma membranes. Three distinct moieties.
    Biochim Biophys Acta Volume: 598 Page(s): 293 - 304
    05/23/1980 Authors: Glass J; Nunez MT; Robinson SH
  • Heterogeneity of messenger RNA defects in the thalassemia syndromes.
    Ann N Y Acad Sci Volume: 344 Page(s): 101 - 112
    01/01/1980 Authors: Benz EJ; Glass J; Tsistrakis GA; Hillman DG; Cavallesco C; Coupal E; Forget BG; Turner PA; Kantor JA; Nienhuis AW
  • Transferrin binding and iron transport in iron-deficient and iron-replete rat reticulocytes.
    J Lab Clin Med Volume: 93 Page(s): 645 - 651
    04/01/1979 Authors: Black C; Glass J; Nunez MT; Robinson SH
  • Transferrin receptors, iron transport and ferritin metabolism in Friend erythroleukemia cells.
    Biochim Biophys Acta Volume: 542 Page(s): 154 - 162
    08/03/1978 Authors: Glass J; Nunez MT; Fischer S; Robinson SH
  • Mobilization of iron from the plasma membrane of the murine reticulocyte. The role of ferritin.
    Biochim Biophys Acta Volume: 509 Page(s): 170 - 180
    05/04/1978 Authors: Nunez MT; Glass J; Robinson SH
  • Transferrin receptors in developing murine erythroid cells.
    Br J Haematol Volume: 36 Page(s): 519 - 526
    08/01/1977 Authors: Nunez MT; Glass J; Fischer S; Lavidor LM; Lenk EM; Robinson SH
  • Iron transport from Sepharose-bound transferrin.
    Biochem Biophys Res Commun Volume: 75 Page(s): 226 - 232
    03/21/1977 Authors: Glass J; Nunez MT; Robinson SH
  • The cross-linking of 125I-labelled transferrin to rabbit reticulocytes.
    Biochim Biophys Acta Volume: 490 Page(s): 87 - 93
    01/25/1977 Authors: Nuez MT; Fischer S; Glass J; Lavidor L
  • Erythroid cell differentiation.
    Hamatol Bluttransfus Volume: 19 Page(s): 109 - 124
    01/01/1976 Authors: Forget BG; Glass J; Housman D
  • Use of cell separation and short-term culture techniques to study erythroid cell development.
    Blood Volume: 46 Page(s): 705 - 711
    11/01/1975 Authors: Glass J; Lavidor LM; Robinson SH
  • Studies of murine erythroid cell development. Synthesis of heme and hemoglobin.
    J Cell Biol Volume: 65 Page(s): 298 - 308
    05/01/1975 Authors: Glass J; Lavidor LM; Robinson SH
  • Problems of preleukemia.
    N Engl J Med Volume: 289 Page(s): 326
    08/09/1973 Authors: Marmor JB; Glass J
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements